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This thesis examines the hypothesis that dietary
essential fatty acids influence gastric prostaglandin
metabolism and acid secretion and could modify the
natural history of duodenal ulcer.
In healthy controls dietary supplementation with linoleic
acid resulted in an increase in the mean output of PGE
and its main metabolite, a reduction in mean serum
gastrin concentration, a fall in acid secretion and an
increase in the output of soluble mucus. In a group of
patients with healed chronic duodenal ulcers the mean
output of PGE was significantly less than that found in
the controls, whilst the mean output of the PGE
metabolite was higher. Furthermore, dietary linoleic acid
did not increase prostaglandin output, nor did it affect
acid secretion. These findings showed abnormal
prostaglandin metabolism in duodenal ulcer, implying
increased PGE catabolism and a failure to respond
normally to dietary essential fatty acid.
Gastric mucosal injury was induced in normal subjects
using aspirin and 80% ethanol. Linoleic acid pre-
treatment had no beneficial effect upon mucosal injury in
either experimental model, guestioning the role of
endogenous prostaglandins in mucosal protection.
The adipose fatty acid profile of duodenal ulcer patients
6
and matched controls was measured since this reflects
chronic dietary fatty acid intake. Mean adipose %
linoleic acid was significantly decreased in the ulcer
group suggesting that dietary essential fatty acids may
be important in peptic ulcer.
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CHAPTER 1
1. HYPOTHESIS AND AIMS
This thesis was stimulated by the hypothesis that the
decline in the incidence and virulence of peptic ulcer
disease may be related to the marked increase in the
dietary availability of linoleic acid ( Hollander and
Tarnawski, 1986).
There has been a significant decline in the age-specific
mortality from duodenal ulcer disease of men in their
fifth decade in Scotland from 154 deaths/million men in
the 1930's to 24 deaths/million men in 1976 ( Sonnenberg
et al, 1985) (Fig 1:1). During this same period a 200%
increase in the consumption of linoleic acid and other
essential fatty acids has been reported (HMSO 1982,
Welsh and Marston, 1982).
These findings could be of aetiological importance in
peptic ulcer disease because linoleic acid is a major
substrate for prostaglandin synthesis in the gastro-
duodenal mucosa. When linoleic acid is given orally or
intragastrically the output of prostaglandins rises
significantly ( Grant et al, 1988 ; Hollander et al,
1982). Prostaglandins given orally can prevent mucosal
ulceration induced experimentally by aspirin, alcohol,
bile salts or boiling water (Robert et al, 1979 ; Miller,
1983). They also promote gastric mucosal repair
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Fig1:1
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following ulceration ( Tarnawski et al, 1983).
Most of the evidence for the protective role of
prostaglandins on the gastric mucosa comes from studies
involving the oral administration of prostaglandins or
their synthetic analogues. The stimulation of endogenous
prostaglandin formation by dietary precursors (linoleic
acid) provides an ideal opportunity to study the role of
gastric endogenous prostaglandins.
The aims of this thesis were to determine in man whether,
(1) Endogenous gastric prostaglandin formation
could be stimulated by dietary linoleic acid.
(2) To define the effects of dietary linoleic acid
upon gastric acid output, fasting serum
gastrin concentration and gastric mucus
output.
(3) To determine whether patients with duodenal
ulcer disease have an abnormality of
prostaglandin synthesis or degradation.
(4) To determine whether endogenously synthesised
prostaglandins protect against aspirin and
alcohol-induced gastric mucosal injury.
(5) To compare the dietary linoleic acid intake
in duodenal ulcer patients with normal
subjects.
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2. LINOLEIC ACID AND PROSTAGLANDIN METABOLISM
Prostaglandins (PG's) constitute a family of chemically
related fatty acids which are distributed throughout the
body and modulate innumerable biological functions.
Their existence was demonstrated over fifty years ago
when Kurzok (1930) noted that strips of uterus relax or
contract when exposed to semen. In the late 1950's
Bergstrom and Sjovall (1960) isolated prostaglandins in a
pure form and later defined their chemical structure.
Prostaglandins are the products of poly-unsaturated fatty
acid metabolism of which the most important are linoleic
acid and arachidonic acid. These are released from
membrane-bound phospholipids by the action of
phospholipase A2 in response to a variety of physical,
chemical and neuro-hormonal factors. Linoleic acid is an
essential fatty acid with 18 carbons and 2 double bonds
at the C9 and C12 positions (Fig 1:2). Arachidonic acid
has 20 carbons and 4 double bonds and is rapidly
metabolised to oxygenated products by the cyclo-oxygenase
and lipoxygenase pathways. The intermediate cyclo-
oxygenase products are converted to prostaglandins, the
lipoxygenase products to leukotrienes (Fig 1:3).
The natural prostaglandins are analogues of prostanoic
acid which has a cyclopentane ring and two side chains
(Fig 1:2). There are several different classes - the
suffices A, B, C, D, E, F denote different constituents
of the ring and the numerical subscript - 1, 2, 3 denote
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the number of double bonds on the side chain.
Biosynthesis
After linoleic acid is absorbed from the gastro¬
intestinal tract it is converted into longer chain fatty
acids in the liver eg. di-homo X - linolenic acid, and
then stored as a tri-acyl-glyceride (TAG). The formation
of prostaglandin precursors from dietary linoleic acid
and -1 inolenic acid depends on the nutritional status
of the patient and the presence of other fatty acids
which may compete for the cyclo-oxygenase and
lipoxygenase enzyme complexes. Deficiency of essential
fatty acids can result in low prostaglandin output
whereas dietary supplementation can lead to increased
output.
The common precursor of prostaglandins, thromboxanes
(TX), and leukotrienes are three naturally occurring
eicosapolyenoic acids (eicosa = 20 ); eicosatrienoic acid
( or di-homo (f -linolenic acid ), eicosatetraenoic acid
(or arachidonic acid ) and eicosapentaenoic acid. In man
arachidonic acid is by far the commonest and gives rise
to the series II prostaglandins. It is either derived
from linoleic acid or ingested itself. It is esterified
and stored as tri-acyl-glycerides throughout the body as
a component of phospholipids in cell membranes.
Hydrolysis of these esters provides the first rate
controlling step of prostaglandin formation (fig 1:4).
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Fig. 1:4 Regulation of Prostaglandin Metabolism





























The specific metabolites of the arachidonic acid cascade
vary between tissues and species. The first product of
cyclo-oxygenase is an unstable cyclic endoperoxide PGG2
which can proceed directly or via a peroxidase to PGH2,
the common intermediate for TXA2, PGD2, PGE2, PGI2 anc*
PGF20(k. An endoperoxide isomerase converts PGH2 to either
PGE2 or its isomer PGD2. The combined action of this
isomerase and reductase yields PGF2Q(_.In some tissues
9-keto reductase catalyses the conversion of PGE2 to
PGF2^. PGE2 may then undergo dehydration to PGA2 and
isomerisation to PGB2 and PGC2. PGH2 can be converted by
the enzyme prostacyclin synthetase to PGI2 which is very
unstable, hydrolysing to its stable metabolite 6-keto
PGF-^ (GranStrom, 1981). The other main route of PGH2
metabolism is to TXA2• This is yet another unstable and
highly active compound formed by the thromboxane
synthetase enzyme complex. T5CA2 is hydrolysed non-
enzymatically to the hemiacetal oxane TXB2.
The chain of events leading to prostaglandin and
thromboxane synthesis can be initiated by diverse
stimuli such as deformation of cell membranes,stretching
of blood vessels or visceral distension (Piper and Vane,
1971 ; McGiff et al, 1972 ) ; even eating causes
increased prostaglandin output (Ahlquist et al, 1983).
Any damage to tissues (Granstrom et al, 1982) such as
acute ischaemia, trauma, hypoxia and inflammation
(Crampton et al, 1987; Williams , 1983) can lead to the
release of lysosomal enzymes; these include
20
phospholipase A2 which in turn hydrolyses linoleic and
arachidonic acids from their membrane-bound
phospholipids.
Not all metabolites are formed in all tissues and the
relative amounts of cyclooxygenase and lipoxygenase
vary between tissues. Most tissues seem to be able to
synthesise prostaglandin endoperoxides from free
arachidonic acid but the factors which control the
subsequent steps are poorly defined. Lung, spleen,
gastro-intestinal tract, thyroid and adrenals are able to
synthesise a wide range of products whereas other tissues
are more selective: mast cells produce mainly PGD2,
seminal vesicles mainly PGE2, vessel walls mainly PGI2
and platelets mainly TXA2.
Control of the prostanoid cascade
Non-steroidal anti-inflammatory drugs (NSAIDS) are potent
inhibitors of prostaglandin synthesis, they prevent the
formation of endoperoxides. The sensitivity of
cyclooxygenase to NSAID's varies between tissues
(Ferreira, 1981). Aspirin inhibits the production of
TXA2 in platelets at doses which do not affect the
production of PGI2 in the endothelial cells, thereby
reducing platelet aggregation.
Glucocorticoids reduce prostaglandin synthesis by
inducing proteins (lipomodulins) which have anti-
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phospholipase properties and so block their release from
their biosynthetic site (Fig 1:4) (Hawkey et al, 1982).
Substrate analogues, end products and leukotrienes all
have feedback on the pathway. There are also a large
number of "permissive" hormones and co-factors, including
ADH, angiotensin II, noradrenalin and bradykinin, which
increase phospholipase A2. TSH, insulin and ACTH
stimulate prostaglandin production from arachidonic acid.
Other co-factors include iron, cytochromes, ascorbic
acid, acetyl choline and copper (Sih et al, 1970).
Prostaglandins are not stored but they are produced in
response to the appropriate stimuli.
Degradation and metabolism
There are many mechanisms by which prostaglandins are
catabolised or inactivated. The prostaglandin
endoperoxides are highly unstable and only exist
momentarily in vivo. Other prostaglandins have longer
half-lives but still only survive minutes in the acid
medium of the stomach. It can be difficult to measure
their concentration in vivo so their more stable
metabolites are measured as an indirect marker.
The first step in prostaglandin degradation is the
oxidation of the C15 hydroxyl group by 15-hydroxy
prostaglandin dehydrogenase (PGDH) (Fig 1:5). The 15-
keto group is then reduced by A-3 reductase (PGR) to the
22
Fig1:5
ProstaglandinEdegradationanmetabol sm p-oxidation(-2carb s) (theco-hydroxylgroup isconvertedtCOOH)
13,14-dihydro /\-3 derivatives. Subsequent B-oxidation
and U-oxidation of the side chains occurs giving rise to
the dicarboxylic acids. Both PGDH and PGR are
intracellular enzymes.
TXA2 is very unstable and converts to TXB2 spontaneously
which then follows the main catabolic route. PGI2 is
also hydrolysed spontaneously to inactive 6-keto PGF-^^ .
3. PROSTAGLANDINS AND GASTRIC PHYSIOLOGY
Prostaglandin E, F and I2 are all synthesised throughout
the gut. ( Moncada et al, 1977; Ahlquist et al, 1982;
Bennett et al, 1977; Peskar et al, 1980 ). In man the
predominant prostaglandin in the gastro-intestinal tract
is PGE (Bennett et al, 1968 ). This discussion will
therefore concentrate on PGE and its main metabolite 13,
14-dihydro 15-keto PGE2 (PGEM). The effects of PGE on
the stomach and duodenum are summarised in Fig 1:6.
Acid secretion
One of the most important effects of prostaglandins on
the stomach is acid inhibition ( Johansson, 1985). This
occurs whether the prostaglandin is given intravenously
or orally (Classen et al, 1971; Horton et al, 1968).
Pharmacological analogues are also potent acid inhibitors
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The mechanisms by which prostaglandins act on the cell
are not fully understood. In dogs prostaglandins have a
greater effect on the stomach when administered topically
onto the gastric mucosa rather than into the duodenum
(after surgical ligation of the pylorus) suggesting a
direct effect on the cell (Konturek et al, 1978;
Robert, 1981 ) . In human experiments PGE2 analogues
are also more effective when given intragastrically than
into the duodenum or jejunum (Nylander and Andersson,
1974) .
At a cellular level it is likely that prostaglandins
inhibit acid secretion at a step beyond the H2 receptor
locus and reduce intracellular cAMP formation (Fig 1:7).
They thus block the main pathway for the excitation of
parietal cells by all secretogogues (Levine et al, 1982;
Soil, 1980).
Prostaglandins may also mediate gastrin. In normal
subjects PGE analogues suppress the gastrin response to a
meal (Ippoliti et al, 1981). The effect of prosta¬
glandin on gastrin in patients with duodenal ulcer is
controversial (Mahachai et al, 1985; Tytgat et al,
1981), and will be discussed in chapter 2.
Gastric mucosal protection
The other effects of prostaglandins on the gastric mucosa
can be broadly grouped under the heading "cytoprotection"
i.e. the ability to protect the gastric mucosa against
26
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injury independent of an acid-reducing effect. Robert
(1984) defines cytoprotection as "a label used to
describe the package of physiological mechanisms which
protect gastric and intestinal mucosa from acid, pepsin,
bile and other known ulcerogens". Cytoprotection is a
poorly understood concept and involves a number of
mechanisms. It seems to be a non-specific effect because
almost every prostaglandin confers some protection
although not all prostaglandins suppress acid secretion
(eg. PGF20C).
Exogenous prostaglandins given in doses insufficient to
suppress acid secretion can prevent gross mucosal lesions
in the stomach against a wide variety of irritants
(Robert et al, 1979). Small doses of gastric irritants
can protect against subseguent larger doses by
stimulating endogenous prostaglandins; this phenomenon
was labelled "adaptive cytoprotection" by Robert in 1979.
It has been further studied by Konturek et al ( 1982).
This stimulation of endogenous prostaglandins has been
implicated as a mechanism of action of several
therapeutic agents eg. Colloid Bismuth Subcitrate
(Konturek et al, 1987) antacids and Ranitidine
(Rachmilewitz et al, 1986 ).
Prostaglandins do not completely protect the gastric
mucosa against necrotising agents. It appears that the
superficial layers of the epithelium undergo extensive
damage but that the deeper layers are protected
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(Tarnawski et al, 1985). Within the deeper layers lies
the cellular proliferative zone and since it is
protected, regeneration occurs.
"Cytoprotection" has now been replaced by the more
appropriate term "gastric mucosal protection". This
involves many mechanisms:-
(a) Stimulation of mucus and bicarbonate secretion:
In man the pH of the gastric mucosal epithelium is
maintained at around pH 7 despite an intra-luminal pH of
1-2 (Bahari et al, 1982). This involves the secretion
of a glycoprotein-rich mucus gel which acts as an
unstirred layer. It is negatively charged and retards H+
and pepsin from diffusing back towards the cellular
surface (Williams and Turnberg, 1980). Prostaglandins
have been shown to stimulate mucus production (Johansson
and Kollberg, 1979; Bolton et al, 1978).
Bicarbonate is secreted by epithelial cells and is
trapped between the mucus layer and the cell surface. It
neutralises acid which enters the mucus layer, converting
it to CC>2 and water. Prostaglandins have been shown to
increase bicarbonate secretion (Rees et al, 1984;
Feldman, 1983; Isenberg et al, 1986). Non-steroidal
anti-inflammatory drugs have the opposite effect. Mucus
is important in protecting the gastric mucosa; Dekanski
et al (1975) showed an inverse relationship between the
amount of mucus and the extent of drug-induced erosions
in rats. The mucolytic agent N-acetyl cysteine can
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counteract the protective activity of mucus (Zlotoff et
al, 1982). Acetazolamide (which inhibits gastric mucosal
bicarbonate secretion) has a similar effect (Kollberg et
al, 1981).
(b) Effect on adenyl cyclase:
Soli et al (1978) found that prostaglandin E stimulates
the formation of cAMP in non-parietal cells. Many of
these cells are located on the mucosal surface and
release mucus into the lumen . This contrasts with the
effect of PGE on the parietal cell where PGE reduces
intra-cellular cAMP and blocks hydrogen ion
secretion.
(c) Sodium pump:
Sodium is normally pumped from the luminal side to the
serosal side of gastro-intestinal cells. This is
enhanced by 16,16-dimethyl PGE2 (Bowen et al, 1975), and
reversed by indomethacin (Chaudhury and Jacobson, 1978).
In injured cells this sodium flux is impaired and anions
accumulate intracellularly, leading to retention of
water, oedema and cell necrosis.
(d) Mucosal barrier:
Several prostaglandins have been shown to protect the
mucosal barrier. This is another concept which is not
fully understood but prostaglandins prevent alterations
in pH across the cell wall caused by aspirin,
indomethacin and ethanol (Cohen et al, 1975; Tepperman et
30
al, 1978). The mechanism of this protection has not been
elucidated.
(e) Gastric mucosal circulation:
Doses of PGE-^, PGE2, and PGI2 which suppress gastric
acid secretion also increase gastric mucosal blood flow
whereas PGF2^ decreases gastric mucosal blood flow in
animals (Broughton-Smith et al, 1978; Konturek et al,
1979) .
(f) Repair mechanisms:
It has been observed that prostaglandins do not prevent
injury to the superficial mucosa but protect the deeper
layer where cell proliferation occurs (Tarnawski et al,
1985). This allows prompt re-epithelialisation of the
denuded mucosa. PGE has been shown to enhance DNA, RNA,
protein and collagen synthesis in cutaneous wounds
(Lupulescu, 1975) but this has not been demonstrated in
the gastric mucosa ( Miller et al, 1982). Long term
treatment with prostaglandins does lead to gastric
mucosal hyperplasia in both animals (Reinhart et al,
1983) and man (Tytgat et al, 1982).
Although gastric mucosal protection involves several
mechanisms which can be demonstrated in vitro, their
significance in vivo is far from clear.
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4. DUODENAL ULCER AND PROSTAGLANDINS
Peptic ulcers occur because of an imbalance between
mucosal protective factors and injurious luminal factors.
The mucosal protective factors include the mucus layer,
mucosal bicarbonate secretion, blood flow and the
regenerative capacity of the proliferative zone (Fig
1:8). Local prostaglandins influence these, although
other factors are also involved. The main injurious
factors are acid, pepsin, bile reflux, stasis, NSAID's
and alcohol. Since prostaglandins influence these
protective mechanisms, and exogenously administered
prostaglandins analogues heal ulcers, it is possible that
a defect in prostaglandin metabolism may be an important
aetiological factor in peptic ulcer disease.
This hypothesis has been studied in three ways
1. Several groups have directly examined the synthesis
of prostaglandins in mucosal biopsies from the antrum and
duodenum. Others have looked at the output of
prostaglandins in gastric juice. The findings are
confusing and in some cases conflicting and are discussed
fully in Chapter 2.
2. An alternative approach is to inhibit gastroduodenal
prostaglandin metabolism. There is accumulating evidence
that NSAIDS are associated with the development of peptic
ulcer, particularly when complicated by perforation or
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Skyring, 1969; Piper et al, 1981; Jick, 1981).
Furthermore, corticosteroids, which are associated with
the development of peptic ulcer, inhibit phospholipase
A2 release.
3. The final approach has been to examine the
therapeutic effects of prostaglandin in experimental
peptic ulcers. Pre-treatment with the prostaglandin
analogues Misoprostol (Cohen et al, 1985) and Arbaprostil
prevent aspirin induced gastric erosions. Several
clinical trials have shown the efficacy of these drugs
in peptic ulcer (Van Trappen et al, 1982; Bardhan et
al, 1984), although they may act by suppressing acid
rather than by augmenting gastric mucosal protection
(Hawkey and Walt, 1986).
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1. INTRODUCTION
Chapter I discussed the evidence that essential fatty
acids are the biological precursors of prostaglandins and
that prostaglandins have important effects upon
gastroduodenal physiology. In the series of experiments
described in this chapter, the effects of dietary
linoleic acid supplementation on gastric acid secretion,
output of PGE in the gastric juice, mucus output and
fasting serum gastrin concentration were studied in
healthy controls and in patients with duodenal ulcer
disease. Hollander and Tarnawski had previously
demonstrated in rats that dietary supplementation with
arachidonic or linoleic acids induced an enormous
increase in gastric prostaglandin concentration
(Hollander et al 1982, 1985). PGE concentration
increased from 880pg/ml to 4100ng/ml after
supplementation - a 5000-fold increase. Schepp et al
( 1988 ) also showed that rats fed diets deficient in
linoleic acid exhibited decreased gastric PGE secretion
and this could be overcome by dietary linoleic acid
supplementation.
No studies examining the relationship between dietary
essential fatty acids ingestion and gastric PGE secretion
had been performed in man. This is of interest because it
relates to the hypothesis suggested by Hollander and
Tarnawski (1986), that the decreasing virulence and
incidence of peptic ulcer disease might be related to
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increased essential fatty acid ingestion. If dietary
linoleic acid favourably affects the gastroduodenal
luminal milieu, it is possible that dietary manipulation
might affect the natural history of duodenal ulcer
disease.
In order to discriminate between the specific effects of
linoleic acid (a poly-unsaturated fatty acid) and any
non-specific effect of fatty acids, control experiments
using the saturated fatty acid stearic acid were
performed.
The aims of the experiments described in this chapter
were :
1. To compare gastric prostaglandin, acid and mucus
secretion and fasting serum gastrin concentration
in duodenal ulcer patients with normal subjects.
2. To determine the effects of dietary linoleic acid
upon gastric physiology - gastric prostaglandin
output, gastric acid secretion,mucus output and
fasting serum gastrin concentration.
2. MATERIALS AND METHODS
Subiects
14 healthy male volunteers aged 20 - 41 years (mean 31)
were studied. All were non-smokers, none abused alcohol
nor took any medications. None had dyspepsia and peptic
ulcer was excluded by endoscopy. Nine were studied
before and after a period of dietary supplementation with
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linoleic acid. The remaining five subjects were studied
before and after dietary stearic acid.
Seven patients aged 29 - 69 years (mean of 42 years) with
endoscopically proven duodenal ulcer were studied. Their
ulcers had healed following a course of H2 receptor
antagonists and all had completed treatment at least 3
weeks prior to the study. Endoscopy confirmed that the
ulcers had healed. None abused alcohol, 3 smoked (10 - 15
cigarettes per day) but did not smoke during the study
period. No drugs other than linoleic acid were taken
during the study.
Design
Each subject was studied over a 14 day period (fig 2:1).
On entry to the study a 10 ml venous blood sample was
taken for measurement of fasting serum gastrin
concentration. Endoscopy was performed using an Olympus
GIF P10 forward viewing instrument. Intravenous sedation
was not given although the pharynx was sprayed with
Lignocaine spray. A size 10 FG nasogastric tube was then
positioned in the stomach and after aspiration of resting
juice, the gastric contents were continuously aspirated
using a vacuum pump. At 15-minute intervals residual
gastric juice was aspirated manually using a syringe.
Three or four 15-minute basal samples were obtained,
0. 6ug/kg of Pentagastrin (Peptavlon, ICI) was injected














Each subject was studied before and after a 14-day period
of dietary fatty acid supplementation to their normal
diet. Five normal subjects took 1. 5g of linoleic acid
per day (in 3 divided doses), four normal subjects
received 3g of linoleic acid per day (in 3 divided
doses) and five control subjects took 3g of stearic acid
per day. All the ulcer subjects received 3g of linoleic
acid per day.
One hour after taking the last dose of fatty acid each
subject was studied in exactly the same manner as on
entry to the study; blood was taken for gastrin levels,
endoscopy was performed to confirm normal appearances of
stomach and duodenum, basal and pentagastrin stimulated
gastric juice was collected.
Linoleic acid was prepared as a micellar suspension in
the non-ionic detergent Pluronic F68. The product was
administered in a gelatin capsule which dissolves in the
acid medium of the stomach. Identity and purity were
confirmed repeatedly over the period of the experiments
by gas chromatography - mass spectrometry (GC-MS). Fig
2:2 depicts a representative trace. Samples of stearic
acid were subjected to similar analysis. Experiments in
animals had previously shown that Pluronic F68 has no
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Analysis of biological fluids
Gastric juice was analysed for acid, prostanoids and
mucus. Serum samples were analysed for gastrin.
a) Gastric acid output
Two 5 ml aliquots of gastric juice were taken from each
15-minute period of gastric aspiration for measurement of
hydrogen ion concentration. This was measured in
duplicate and mean values calculated.
Acid concentration was determined by back titration to
pH7 with 0. IN NaOH using an automated analyser (PH M82
pH meter, Radiometer, Copenhagen). Hydrogen ion output
was calculated for each 15-minute period from the
product of concentration and volume. The values
determined before pentagastrin will be referred to as
"basal" acid output, those following pentagastrin as
"maximal" acid output.
b) Prostaglandin estimation
PGE and PGEM concentrations were measured using
radioimmunoassay.
(i) Materials Tritiated prostaglandins were obtained
from Amersham International (Bucks) and New England
Nuclear (Stevenage). Pure standard prostaglandins were
purchased from Sigma (Poole, Dorset). Methyloximating
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reagent was made from methoxyamine hydrochloride and
anhydrous sodium acetate (obtained from Eastman Kodak).
Antibodies to PGE and PGEM were kindly donated by Dr R
Kelly, MRC Reproductive Biology Unit, Edinburgh. They
were obtained using rabbits as described by Kelly et al
(1986).
(ii) Handling of gastric juice. Immediately after being
collected the volume of gastric juice was measured. 10
mis was removed for measurement of acid concentration as
previously described, and the pH of the remainder was
adjusted to 7 to minimise conversion of PGE to PGA.
Samples were then frozen and stored at -20°C.
(iii) Methyloximation Methyloximation of prostanoids
increases their stability. A methyloximating solution
was prepared by mixing 5g of methoxyamine hydrochloride,
41g of anhydrous sodium acetate, 50 mis of ethanol and
500 mis distilled water, the pH was then adjusted to 5.6.
2 mis of neutralised gastric juice were mixed with 2 mis
of methyloximating solution and left to stand overnight.
Methyloximating efficiency had previously been assessed
by using tritium labelled 6-keto prostaglandin F1<x and
carbon-14 labelled PGE2• HPLC separation before and
after methyloximation showed 97% conversion for 6-keto
PGF10C an<^ f°r pge2 '
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(iv) Radioimmunoassay procedure. Radioimmunoassay was
performed in triplicate using a standardised technique.
The protocol is illustrated in Tab 2:1 .A standard curve
using commercially obtained PGE and PGEM was constructed.
Concentrations ranged from 0.02-10 ng/tube.
"Non-specific binding" - each tube contained lOOul
of tritiated label and 200ul of tris-EDTA buffer. As
there was no antibody nor unlabelled antigen, any
binding of the tritiated label was due to non-specific
effects.
"Reference standard" or "maximum binding" - Each
tube contained lOOul of tritiated label, lOOul of
tris-EDTA buffer and lOOul of antiserum. There was
tritiated antigen and antiserum but no unlabelled
antigen so that binding of the labelled antigen was
maximal.
"Standard curve" - For each assay a standard curve was
run, and differing quantities of unlabelled
prostaglandin ranging from 0.02ng to lOng (in 100 ul)
were added to lOOul of tritiated prostaglandin and
lOOul of antiserum. When larger quantities of
unlabelled prostaglandin were added relatively less
of the tritiated prostaglandin bound to the antibody
and the counts were lower, when smaller amounts of
unlabelled prostaglandin were added more of the
unlabelled prostaglandin bound to the antibody and the
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table 2:1
protocol for performing radioimmunoassay
3h tris unknown
label edta anti¬ standard antigen
antigen buffer serum curve sample
total counts 100 — — — —
non-specific
binding ( nsb)
100 200 — — —
reference
standard
100 100 100 — —
standard
curve
100 — 100 100 —
test sample 100 — 100 — 100
quality
control (qc)
100 50 100 50 —
all figures are in microlitres
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counts were high. The standard curve has a
reverse sigmoid form; a typical example is shown in
fig 2:3.
"Test samples" - lOOul of tritiated label, lOOul of
antiserum and lOOul of the sample to be tested were added
together. The amount of tritiated antigen bound to the
antiserum can be counted and is inversely proportional to
the amount of unlabelled antigen (sample) present. The
quantity of antigen present in the sample is calculated
with reference to the standard curve.
"Quality control" - lOOul of tritiated prostaglandin are
added to lOOul of antiserum, 50ul of tris-EDTA buffer and
50ul of a known amount of unlabelled prostaglandin. The
result gives an estimate of intra-assay precision.
Samples of methyloximated gastric juice were assayed in
identical manner; 100 ul of tritiated label, 100 ul of
antiserum and 100 ul of the sample being tested in
triplicate. The Samples were vortex mixed and incubated
for twelve hours at 4°C, covered by aluminium foil (to
prevent evaporation). Once equilibrium had been attained
0.8 ml of polyethylene glycol (PEG) was added (forming a
plug which remained in the tube). Tubes were
centrifuged at 3000 rpm (1684 x G) at 4°C for fifteen
minutes then inverted and allowed to drain for fifteen
minutes to enable all the unbound prostaglandins to be




each tube, the tubes were shaken to dissolve the pellet
and then placed in a self loading B-counter for one
minute (1216 Rackbeta liquid scintillation counter, LKB
Wallac, Milton Keynes, England).
Attention was paid to detail, contact with other workers
using prostaglandins was avoided and the risk of
contamination of utensils was avoided by using disposable
equipment, automatic dispensers and pipettes.
(v) Performance of the radioimmunoassay
Specificity: the specificity of the assay had
previously been determined by Kelly et al. There
was almost no cross-reactivity between the PGE
radioimmunoassay and PGA, PGEM, 6-keto PGF^
and linoleic acid. There was 53% cross reactivity
between PGE^ and PGE2 and 31% between PGE3 and
PGE2. There was no cross-reactivity between the
PGEM assay and PGA, PGE, 6-keto PGF-^ and
linoleic acid.
Sensitivity: the sensitivity of both the PGE
and PGEM assay was 20 pg/100 ul in gastric juice.
Precision: the intra-assay precision of PGE
ranged from 13.5 - 26.4%. That of PGEM was 12.1 -
22.3% (relative SD). Inter-assay precision of PGE
was 14.8%; that of PGEM was 9.4% (relative SD).
Reproducibility: reproducibility was assessed by
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repeated assays on the same specimens. In
representative samples the correlation
coefficient was 0.98. A similar value (0.78) was
obtained by an independent worker using the sample
(Figs 2:4 and 2:5).
c) Mucus output
Quantifying mucus gel secretion poses several
methodological problems as it is necessary to distinguish
between adherent mucus and soluble mucus. Initially an
attempt was made to measure the adherent mucus layer
using a pachometer modified from a method described by
Douthwaite and Spence (1986). The method was found to be
unsuitable in this study because only small biopsies
were obtainable from the gastric mucosa resulting in
crushing, crumpling and distorting of the mucus layer.
The technigue was therefore abandoned.
i) Assay
Soluble mucus output was measured using the method
described by Baron et al (1986). This assumes that
mucus comprises the vast majority of the solid component
of the gastric juice. The agueous components are
removed by dialysis and lyophilisation, then homogenised
to disperse any insoluble mucus, and finally centrifuged
at 2000G for ten minutes and the volume measured. The
gastric juice was concentrated by rotavapour (when
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Fig 2:4
CORRELATION BETWEEN 2 ASSAYS FOR PG E
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Fig 2:5
CORRELATION BETWEEN 2 ASSAYS FOR PG EM
0 200 400 600 800 1000
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necessary) and dialysed with distilled water for seventy
two hours (five changes of the dialysis fluid). The
mucus output was calculated by multiplying the
concentration of non-dialysable material in the sample of
gastric juice by the corrected volume of the juice
produced in the basal and stimulated hours.
d) Serum gastrin concentration
After an overnight fast 10 ml of venous blood was removed
from the subject, the sample was spun down immediately,
the serum removed and stored at -20°. The serum gastrin
concentration was measured using radioimmunoassay by the
Department of Biochemistry, Glasgow Royal Infirmary.
Detection limit of the assay was 15 ng/1, the within
batch co-efficient of variation was 7% and the between
batch variation was 12%. The anti-serum reacts with
gastrins containing 17 and 34 amino acids and to a lesser
extent with big, big gastrin.
3. RESULTS
Endoscopy, collection of gastric juice and ingestion of
the fatty acids were well tolerated. Two control
subjects receiving linoleic acid developed mild diarrhoea
(loosening of stool without increased frequency) but
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there were no other side effects associated with either
linoleic or stearic acid ingestion. Compliance was
determined by interview, counting of capsules and by the
observation of partially broken down capsules with blue
discolouration at endoscopy. Endoscopic appearances were
all normal or showed ulcer scars in the ulcer group.
a) Gastric acid output
The results of gastric acid secretion are presented in
tab 2:2 and Fig 2:6. In the 9 healthy controls receiving
linoleic acid mean basal acid output was 6.2 mmol/hr
(±1.5) (SEM) before linoleic acid and 5.3 mmol/hr (± 1.2)
after linoleic acid (p > 0.05). Mean maximal acid output
fell from 35.1 mmol/hr (± 3.5) prior to linoleic acid to
30.0 mmol/hr (± 2.7) after linoleic acid (p < 0.05 ).
In the 7 patients with duodenal ulcer mean basal acid
output was 3.0 mmol/hr (± 0.8) before linoleic acid and
1.8 mmol/hr (± 0.6) after linoleic acid (p > 0.05). Mean
maximal acid output was 29.2 mmol/hr (± 2.3) before
linoleic acid and 28.5 mmol/hr (+ 2.7) after linoleic
acid (p > 0.05).
In the 5 healthy controls taking stearic acid mean basal
acid output was 3.8 mmol/hr (± 1.7) and 1.8 mmol/hr
(± 1.1) after stearic acid. Mean maximal acid output was
25.0 mmol/hr (+ 2.3) before stearic acid and 23.7
mmol/hr (± 1.4) after stearic acid (p > 0.05). There was
no significant change in acid output in this control
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Tab 2:2
Mean (+ SEM ) gastric acid ouput in control and
duodenal ulcer subjects before and after dietary





Before After Before After
controls taking






acid 3.0 (0.8) 1.8 (0.6) 29.2 (2.3) 28.5 (2.7)
n=7
controls taking
stearic acid 3.8 (1.7) 1.8 (1.1) 25.0 (2.3) 23.7 (1.4)
n=5
*











group indicating that the observed significant increase
after linoleic acid is not a non-specific effect of fatty-
acids .
b) Prostaglandin output
The results of gastric PGE and PGEM output are presented
in Tab 2:3 and in figs 2:7 and 2:8. Mean immunoreactive
PGE output was significantly lower in ulcer subjects than
controls (p < 0.01). In the controls, but not ulcer
subjects, PGE output increased significantly following
dietary linoleic acid. Mean PGEM was significantly
higher in the ulcer patients than in the control group
prior to linoleic acid (fig 2:9). The ratio of
PGE:PGEM was reversed in control and ulcer subjects
(PGE:PGEM ratio of approximately 2.5:1 in normal
subjects and 1:6 in the ulcer group). Following
linoleic acid PGEM output increased in the normal
subjects and the magnitude of this increase was greater
than that of PGE. The PGE: PGEM ratio approached unity
after linoleic acid. In ulcer subjects there was no
increase in mean PGEM output and the ratio of PGE : PGEM
was unchanged following linoleic acid .
Stearic acid did not affect PGE or PGEM output in the
normal subjects. The absolute levels of PGE and PGEM were
lower than in the control group taking linoleic acid
because there was a delay before they could be assayed.
Tab 2:3
Mean (+ SEM) PGE and PGEM output in control and duodenal
ulcer patients before and after dietary supplementation
with linoleic acid or stearic acid
PGE output PGEM output
ng / hour ng / hour
Before After Before After
controls taking
*• ★
linoleic acid 498 (110) 1230 (465) 192 (19) 1335(708)
n = 9
DU patients * ★ ★★
taking linoleic 138 ( 41) 96 (21) 840 (439) 600 (173)
acid n = 7
*
= differs from value before linoleic acid ( p< 0.01)
**
= differs from corresponding values in controls ( p< 0.01)
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The results of mucus output are shown in Table 2:4. In
the controls there was a significant increase in the
output of mucus from 432 mg/hour (± 47) before linoleic
acid to 593 mg/hour (± 83) after linoleic acid. In
contrast, there was no significant difference in mucus
output in the duodenal ulcer patients: it was 367 mg/hour
(± 80) before linoleic acid and 388 mg/hour (± 95) after
linoleic acid (p < 0.05).
d) Serum Gastrin Concentration
In control subjects mean fasting serum concentrations
increased from 19.2 ng/1 (± 3.3) (SEM) to 30.9 ng/1
(± 4.1) following dietary linoleic acid (p < 0.01).
This is shown in fig 2:10 where it can be seen that in
all but one subject the mean serum gastrin concentration
increased.
In ulcer patients the mean serum gastrin concentration
did not significantly change following linoleic acid;
33.4 ng/1 (± 4.5) before linoleic acid falling to 26.0
ng/1 (± 3.5). This is shown in fig 2:10.
In control subjects receiving stearic acid there was also
no significant difference in gastrin concentration before
or after fatty acid supplementation; it was 25 ng/1
(± 4.0) before stearic acid and 18 ng/1 (± 3.8) after.
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Tab 2:4
Mean ( + SEM) mucus output in control and duodenal ulcer
subjects before and after dietary supplementation with
linoleic acid
Mucus output ( mg/ hr )









367 (80) 388 ( 95)
*
= differ from value before linoleic acid ( p < 0.05 )
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Prostaglandins are notoriously unstable; prostacyclin
has a half-life of thirty seconds before being converted
to 6-keto F-j^ ,PGE is rapidly converted to PGA in an
acidic environment, and PGA is rapidly converted to PGC
in alkaline media. In order to minimise these problems
samples of gastric juice were neutralised as soon as
possible after being aspirated and samples were
derivatised to their methyloxime. Methyloximation is
common in gas chromatography-mass spectrometry (Kelly R
et al, 1983). The technique has also been described for
radioimmunoassay (Kelly and Abel, 1986) but is not in
widespread practice. The process is simple, the reaction
occurs at room temperature, and specific and sensitive
antisera can be raised against the prostaglandins as
their methyloximes.
Some workers extract prostaglandins from gastric juice
prior to radioimmunoassay. The main reasons in favour of
extraction are: to concentrate the prostaglandin, to
dissociate the prostaglandin from any protein present, to
remove any interfering factors, and to remove any other
interfering prostaglandins if the antiserum is not
particularly specific.
In this study it was decided not to extract
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prostaglandins for several reasons: the level of
prostaglandins in gastric juice is high and can be
measured directly, it was possible to increase the
sensitivity of the assay using a labelled ligand of
higher specific activity , and omitting extraction avoids
the problem of estimating recovery. This can be a problem
as recovery can be low, variations occur, and non¬
specific interfering factors can be introduced. In a
series of preliminary experiments ( tab 2:5) it was shown
that for the concentrations found in gastric juice, this
step was unnecessary. Using the Vac-Elut extraction
system results for PGE output were almost identical to
the unextracted values.
Assaying the main metabolite of PGE - 13,14 dihydro 15-
keto PGE2 gives an indirect marker of any PGE which may
have been missed by the assay. PGA was not assayed in
this study because the only antiserum available had
unacceptably high cross-reactivity with other
prostaglandins.
(ii) Mucus assay
It is difficult to measure adherent mucus and only the
soluble mucus fraction was measured. The method used is
relatively crude, assuming that all the non-dialysable
component of the gastric juice is mucus. In fact this
appears reasonable since the only other large molecular
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Table 2:5






6712 100 prior to extraction
5934 88 full supernatant
41 0.7 straight through
column
38 0.6 water wash
68 1 hexane wash
6625 99 ethyl acetate
Tracer was added to gastric juice and spun down. The
supernatant was then added to the " Vac - elut" column.
Most of the prostaglandin adheres to the column , and the
small amount that goes through is counted. Ethyl acetate
is poured into the column : this removes the prostaglandins
which have adhered to the column , and the effluent is
counted. This value represents the quantity of extracted
prostaglandin. The results demonstrate that extraction of the
samples is not necessary.
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components are digestive enzymes, present in relatively
low concentrations.
Mucus swallowed from the upper respiratory tract may have
produced some artifactual increase in mucus output since
the pharynx was not aspirated during the experiments.
Since the amount of swallowed mucus is probably similar
for the same individual studied on two occasions this is
unlikely to have significantly affected the conclusions
of the experiments.
The only solid material which may have influenced
apparent mucus secretion was the gelatine capsule of the
fatty acid capsule but this was either removed prior to
dialysis or had passed through the pylorus before the
juice was collected.
b) Prostaglandin output
This study has shown striking differences in gastric
prostaglandin metabolism between normal subjects and
patients with duodenal ulcer. Mean gastric PGE output
was markedly lower in the duodenal ulcer patients; the
finding of increased PGEM output strongly suggests that
this was due to increased catabolism of PGE, rather than
to decreased PGE formation. In normal subjects there was
a marked rise in gastric output of PGE following linoleic
acid, but this did not occur in ulcer patients.
The present observations contradict those of Cheung
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et al (1976), who reported increased prostaglandin output
in gastric juice from a small number of patients who had
active duodenal ulcers. The presence of active ulceration
may have resulted in non-specific rises of prostaglandin
output masking an inherent abnormality, because tissue
damage and inflammation stimulate prostaglandin
metabolism and lead to increased PGE output. By studying
patients whose ulcers were in remission, abnormalities
caused by the non-specific effects of tissue damage were
avoided.
Several groups have directly examined gastro-duodenal
prostaglandin metabolism in health and peptic ulcer
disease.
Sharon et al (1983) studied cultured duodenal and gastric
mucosa in healthy and ulcer patients. Accumulation of
PGE2, 6-keto PGF^ and TxB2 from cultured duodenal
mucosa in patients with active duodenal ulcers and in
healthy controls was similar. However,accumulation of the
same prostaglandins in cultured gastric mucosa was
significantly less from patients with active duodenal
ulcers than from healthy controls. The authors
suggested that abnormal prostaglandin metabolism may be
important in the pathogenesis of ulcer disease and
suggest a possible role for exogenous prostaglandins.
Konturek et al (1981) found slightly reduced PGE2-like
activity from biopsies taken from the fundus and antrum
of patients with acute duodenal ulcers compared to
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healthy controls but this did not reach significance.
Crampton et al (1987) found no difference in PGE
synthesis or degradation rates between duodenal ulcer and
normal subjects. They did however find that gastritis
was associated with increased prostaglandin E formation
and that gastric ulcer patients had a reduced synthesis
and degradation of PGE2.
Ahlquist et al (1983) found no difference in the
synthesis of PGE from the duodenal mucosa between
duodenal ulcer patients and controls. However, after a
meal normal subjects had a rise in the synthetic activity
of prostanoids whereas in duodenal ulcer patients there
was a fall in synthetic activity.
Pugh et al ( 1989 ) found that the synthesis of PGE2 was
reduced in patients with active and inactive duodenal
ulcer disease. This decrease occurred both at the ulcer
site and from morphologically normal duodenal and antral
mucosa.
These studies all involved incubating mucosal biopsies
and assessing their capacity to synthesise
prostaglandins. This is open to artifactual disturbances
since the trauma of biopsy, homogenisation and incubation
non-specifically stimulates prostaglandin formation. In
an attempt to overcome this, several groups have looked
at the concentration of prostaglandins in gastric juice.
Conflicting results have also been obtained using this
70
approach.
Hinsdale et al ( 1974 ) found that PGE levels in the
gastric juice of patients with inactive duodenal ulcer
were higher than in normal subjects under basal
conditions. This difference disappeared after
stimulation.
The confusion resulting from these studies may be due to
the fact that insufficient attention was paid to the
instability of prostaglandins, the non-specific
prostaglandin stimulating effect of an active ulcer
diathesis and failure to differentiate between changes in
prostaglandin production and catabolism.
In this study the absolute levels of PGE in healthy
controls were significantly higher than in the ulcer
group (P < 0.01) (498ng/hr compared to 138ng/hr). In the
healthy control group far less metabolite (192ng/hr) was
found compared with PGE ( 498ng/hr), (fig 2:9). In
contrast, in the ulcer group there was far more PGEM
(840ng/hr) than PGE (138ng/hr). In the controls the
ratio of PGE:PGEM was 2.5:1 whereas in the ulcer group it
was 1:6. In this study PGE output was significantly lower
in duodenal ulcer patients compared with controls whereas
PGEM was significantly higher. When taken together the
combined outputs of PGE and PGEM are similar in the 2
groups (690ng/hr in healthy controls, 978ng/hr in ulcer
patients).
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At first glance the lower PGE output ulcer patients seems
at variance with other published series (Konturek et al,
1981; Ahlquist et al, 1983). However when PGE and PGEM
are combined, output is similar in the 2 groups, which is
in broad agreement with Sharon et al (1983) and Crampton
et al (1987). The important difference demonstrated in
this study is that in duodenal ulcer patients far more of
PGE is found as its metabolite. This would suggest
that in duodenal ulcer there is not an increase in the
production of PGE as suggested by Hinsdale et al (1974)
and Cheung et al ( 1976 ) but rather an increase in
metabolism. The reason for this is not clear, although
it could be due to an increase in activity of the enzyme
endoperoxide isomerase. It is unlikely to be due to acid
degradation of PGE to PGA because the acid outputs were
similar in the two groups.
c) Effect of Linoleic acid on Prostaglandin output
Previous work in rodents by Tarnawski et al (1983, 1985)
showed that intra-gastric linoleic acid and arachidonic
acid resulted in enormous increases in PGE output (5,000
fold). Schepp et al (1988) reported similar findings.
Some of this huge increase may have been due to cross-
reaction of their PGE antibody with linoleic acid. This
was not the case in this study where cross-reactivity was
less than 0.001%. Furthermore, in the ulcer group no
increase was found in PGE output after linoleic acid;
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this would not have occurred if there was significant
cross-reactivity between linoleic acid and PGE.
The linoleic acid administered in this study was
virtually 100% pure (shown by GC-MS) and so the
significant increase in PGE output was not due to other
as yet undetermined compounds. Nor was it a non¬
specific effect of fat since dietary stearic acid did not
affect gastric prostaglandin output.
The absence of a rise in gastric prostaglandin secretion
in ulcer patients following dietary linoleic acid was
unexpected. The cause of this abnormality is not
explained in these experiments. It could be due to
defective absorption (unlikely) or defective metabolism.
Further experiments involving incubating biopsies would
be necessary to define this.
d) Gastric acid output
Gastric acid output was similar in the normal subjects
and duodenal ulcer. This was unexpected; it is well
recognised that acid secretion tends to be increased in
duodenal ulcer patients. Nevertheless, the normal
subjects had no endoscopic or clinical evidence of ulcer
whilst the disease group had dyspeptic symptoms and
endoscopically proven ulcer. Many ulcer patients are
found in clinical practice to have normal acid secretion,
illustrating that gastric acid is not the only factor in
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ulcer pathogenesis.
Since prostaglandins are known to suppress acid secretion
it appears likely that the significant decrease in acid
output observed in normal controls taking linoleic acid
was mediated by prostaglandins.
The effect of linoleic upon acid secretion was clearly
not merely a non-specific effect of fatty acid ingestion
because it was not affected by stearic acid.
Linoleic acid had no effect upon either acid or
prostaglandin secretion in ulcer subjects, suggesting
that dietary manipulation of essential fatty acid intake
will not modify the natural history of duodenal ulcer.
This clearly questions the initial hypothesis of
Hollander and Tarnawski (1986).
e) Gastric mucus output
In healthy subjects soluble mucus output was
significantly increased by linoleic acid but not by
stearic acid; mucus output did not increase in ulcer
patients taking linoleic acid. The increase in mucus
output in the healthy controls taking linoleic acid is
probably due to the increase in PGE output because there
was no increase in PGE output in the controls taking
stearic acid nor in the duodenal ulcer patients.
This observed increase in mucus following stimulation of
endogenous PGE agrees with the findings of Sellers et al
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(1986) and Waterbury et al (1986) who administered
prostaglandin E analogues and found an increase in the
adherent mucus layer. Bolton et al (1978), Domschke et
al (1978), Johansson and Kollberg (1978) all found
increases in soluble mucus after administration of PGE
analogues.
f) Serum gastrin concentration
The serum gastrin concentration significantly increased
in normal subjects taking linoleic acid but not when
taking stearic acid. Linoleic acid ingestion was not
associated with changes in gastrin concentration in ulcer
subjects. It is possible that the increases occurring
during linoleic acid ingestion in normal subjects were
secondary to suppression of gastric acid, although the
magnitude of this suppression was small; certainly less
than that associated with H2 receptor antagonist therapy,
which has only modest and inconsistent effects upon
gastrin concentrations. The effects of orally
administered prostaglandin analogues upon serum gastrin
concentration are controversial. Several groups have
measured serum gastrin concentrations after
administration of endogenous PGE or its analogues in
ulcer patients. Tytgat and Huibregste (1981) found no
change in mean serum gastrin concentration in patients
with acute duodenal ulcers who were treated with 15(R)-
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15-methyl PGE2 for four weeks. In contrast Mahachai et
al (1984) found that there was a reduction in mean serum
gastrin concentration in patients with an inactive ulcer
treated with Enprostil (a de-hydro prostaglandin E2
analogue) for one week. Konturek et al (1979) found that
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In experimental animals and man, pharmacological
concentrations of prostaglandins and prostaglandin
analogues protect the gastric mucosa against injury by a
wide variety of damaging agents. These include aspirin
(Cohen et al, 1985), ethanol, sodium hydroxide and
hypertonic saline (Robert et al, 1979). The mechanisms
are incompletely understood although prostaglandins are
known to stimulate gastric mucus and bicarbonate
secretion (Rees et al, 1984 ), and stimulate repair
mechanisms (Tytgat et al, 1982). The clinical
significance of these mucosal protective actions is
controversial; it is likely for example that
prostaglandin analogues heal ulcers by suppressing
gastric acid secretion rather than enhancing mucosal
protection (Hawkey and Walt, 1986). Furthermore,
although the pharmacological effects of prostaglandins
are well substantiated, their physiological role in
gastric function and mucosal repair is poorly understood.
This is partly because it is difficult to reliably
measure prostaglandins in mucosal biopsies and gastric
juice (Samuelsson et al, 1975). A physiological role
has been inferred from the observation of "adaptive
cytoprotection" in which exposure of gastric mucosa to a
low concentration of a damaging agent stimulates local
prostaglandin release and protects the gastric mucosa
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against subsequent exposure to a higher concentration of
the same or another agent. This phenomenon is only-
indirect evidence of a protective role for endogenous
gastric prostaglandins since the sensitizing exposure may
also affect factors unrelated to prostaglandins which
could then protect the stomach.
In this study an alternative approach to defining the
mucosal protective effect of endogenous gastric
prostaglandins has been adopted. This approach is based
upon the observation that gastric prostaglandin output
can be modulated by changing dietary essential fatty acid
intake. Gastric prostaglandin output decreased in rats
fed a diet deficient in linoleic acid (LA), whilst a
linoleic acid-rich diet increased PGE output (Schepp et
al, 1988). Arachidonic acid supplementation both
increases gastric PGE output and protects the rodent fore
stomach against ulceration by ethanol (Tarnawski et al,
1983). In the previous chapter it was shown that
relatively modest dietary supplementation with linoleic
acid (3g daily) increased mean gastric PGE output from
498 (± 110)ng/hr (SEM) to 1230 ± (300)ng/hr. The output
of 13,14 dihydro 15-keto PGE2 (the major metabolite of
PGE) increased in a similar manner and gastric acid
secretion was also modestly, but significantly,
depressed. Thus, by stressing the stomach of
individuals before and after the administration of
linoleic acid, the role of endogenous gastric
prostaglandins can be determined. Using this model, it
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was possible to investigate whether changes in dietary-
essential fatty acid intake could influence the
gastroduodenal micro-enviroment, and alter its
susceptibility to damage from non-steroidal anti¬
inflammatory drugs or peptic ulcer.
In the studies described in this chapter the effects of
linoleic acid upon experimental gastric mucosal damage
induced by aspirin and ethanol were determined.
Experimental models of cell injury
a) Aspirin-induced mucosal damage
Aspirin damages the gastro-duodenal mucosa by inhibiting
mucosal protective mechanisms. It inhibits the enzyme
prostaglandin synthetase (Vane , 1971) thereby disrupting
the prostaglandin pathway. The exact mechanism by which
aspirin causes gastric ulceration is not known, but it
has been hypothesized that its ulcerogenic action is due
to the withdrawal of the protective qualities of
prostaglandins (Konturek et al, 1981). Aspirin can
cause lesions whether given intra-gastrically or
parenterally (Bugat et al, 1976; Brodie and Chase, 1967)
and the severity of these lesions can be increased by
gastric acid stimulation or intragastric perfusion of HC1
solution (Guth et al, 1979). The likely explanation
for this observation is that un-ionized aspirin diffuses
from the acidic enviroment of the stomach through the
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mucosa, accumulates within the epithelial cells because
of the high pH and disturbs mitochondrial phosphorylation
and cell buffer system: (Svanes et al, 1979; Spenney and
Brown, 1977). Aspirin also appears to alter mucosal
blood flow, causing venular constriction, capillary
stasis and increased endothelial permeability.
In man, aspirin ingestion causes erythema and erosions in
the gastric mucosa. This can be visualized and measured
at endoscopy and blood loss can be measured in the
faeces. Cohen et al ( 1985 ) have shown that the
prostaglandin analogue, Misoprostol, reduces aspirin-
induced bleeding.
There are two main ways of detecting and measuring blood
loss from the gastro-intestinal tract. These involve
measuring the peroxidase activity of iron containing
compounds or labelling the red cells with a radio-active
tracer. In the former group, the most commonly employed
tests are the guaiac or orthotolidine tests. Both depend
on the peroxidase activity of iron-containing haemoglobin
derivatives, which catalyse the oxidation of guaiac or
orthotolidine in the presence of hydrogen peroxide. Both
are used in clinical practice and there have been many
papers published based on this method. Their validity
has been challenged by Van Essen et al (1985). They found
them to be unsatisfactory as the effect of haemoglobin on
the conversion of orthotolidine is decreased by low pH,
high specific gravity and protein. The presence of
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reducing substances can give false negative results and
oxidising substances can give false positive results.
The results are not always reproducible nor accurately
quantitative.
The Cr51 method of determining gastro-intestinal blood
loss is therefore generally regarded as more reliable
(Rhys Davies 1984). It involves removing a quantity of
blood from the patient, labelling the red cells with
radioactive Cr^, re-injecting the labelled red cells
into the patient and measuring faecal radio-activity. It
is a well-tried method and provides quantitative and
reliable data.
Cr^ is a widely used radio-nucleotide in both clinical
practice (red-cell survival studies and protein-losing
enteropathies) and in medical research. It binds to the
13 chain of adult haemoglobin (HbA) . On average 95% of
red blood cells are labelled with Cr51. Cr51 has a
half-life of 27.8 days and emits gamma-radiation which
can be easily measured. The mean total radiation
exposure in each patient was approximately 2.4 MBq.
b) Alcohol-induced mucosal damage
Alcohol damages the gastric mucosa by several mechanisms
(Oates and Hakkinen, 1988). Concentrated alcohol causes
necrosis of superficial mucosal cells by precipitating
cytoplasmic constituents. In response, mucosal
mast cells release the vasoactive mediators
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leukotriene C4 and histamine, which cause constriction of
mucosal venules followed by dilatation of arterioles,
venous engorgement, increased capillary pressure,
exudation of fluid, haemolysis and subsequent basal
thrombosis, stagnation and cellular death.
In the rat fore-stomach, absolute ethanol causes deep
ulceration which can be prevented by pre-treatment
with prostaglandins, arachidonic acid or linoleic acid.
Hollander and Tarnawski (1985) have shown that
superficial necrosis occurs whether or not animals have
received PGE but in animals receiving PGE cells deep
within the proliferative pits of the gastric gland are
protected and re-epithelialisation is enhanced.
In man, alcohol-induced mucosal ulceration can also be
used as an experimental model of mucosal injury. In this
study, damage was assessed in several ways.
i) The endoscopic appearances following alcohol-induced
damage were assessed using a visual scoring system
modified from Agrawal et al (1987). The problem
with this approach is that it is subjective;
the endoscopist cannot be blinded as to whether
or not linoleic acid had been given because the
remnants of the capsule or green fluid can be seen.
ii) The endoscopic biopsies were taken adjacent to the
damaged area. These were objectively assessed by
an independent histologist who received the biopsies
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in a blinded, random order.
iii) The rate of nuclear proliferation in cells adjacent
to the damaged area was used as an index of cell
viability. This approach has also been used by Hart
Hansen et al (1975) and Boyes et al (1971) in other
studies.
In order to assess nuclear proliferation, the
proliferative area of the gastric pits was studied. In
the antrum these progenitor cells are located in the
isthmus of the gland (Leblond et al, 1948), from which
they divide and migrate to the surface. Epithelial
renewal occurs every 3-5 days but when the epithelium
is damaged, restitution occurs within a matter of a few
hours.
During the cellular repair process, the progenitor
cells synthesise proteins prior to cell division
(mitosis). These cells can be identified (and counted)
in either the synthetic "S" phase or during mitosis
itself. The process of cell division can be divided into
four phases - Gl, S, G2, M (Howard and Pelc, 1953 ).
Cairnie et al (1965) divided renewing tissue into two
compartments: the "P" compartment containing cells
actively engaged in the cell cycle and the "Q"




P Compartment Q Compartment
( proliferative ) ( non-proliferative)
G1
From Aherne et al (1977 )
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"Gl" is a variable period when the cell is
actively functioning; ( Mueller, 1971; Aherne et al,
1977), cells may enter the proliferating cell cycle
or move to the "Q" compartment and become dormant.
In the "S" phase DNA replication occurs.
"G2" is the brief phase when the cell prepares for
the initiation of mitosis.
The "M" phase represents mitosis in which identical
genetic material is apportioned to daughter cells
(Tobey et al, 1971).
For the purposes of this experiment the S phase was
studied. Two methods were used, autoradiography (ARG)
and flow cytometry.
Autoradiography (ARG)
DNA and RNA have three bases in common - adenine, guanine
and cytosine. Only DNA has thymine and only RNA has
uracil. By using tritiated thymidine ("^H-TdR) as a
label, DNA metabolism can therefore be followed. In
essence this involves incubating mucosal biopsies with
H-TdR followed by autoradiography and counting the
number of labelled nuclei.
3H-TdR incorporation is used to determine the proportion
of cells in the cell cycle which are in the "S" phase.
In the context of this study it can also be used to
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indicate of the number of surviving cells.
Flow Cytometry
This is based on the stoichiometric reaction of
fluorescent dyes with DNA. Cells in the G0/G1 phase have
a diploid amount of DNA, cells undergoing mitosis have a
double diploid amount and those in "S" phase have an
amount in between. If cells contain an abnormal amount
of DNA (aneuploid) they can also be detected.
Flow cytometry was originally used to assess cell numbers
and size. It was subseguently developed by Kamentsky et
al (1965) to guantify mucleic acid concentration using
the absorption and scatter of light. In 1969 Mullaney et
al produced the first DNA histogram with clearly defined
G0/G1, S, G2 and M phases. This has had considerable
impact on the study of cellular events. Its main
advantage is that it enables the quantification of a
number of parameters on a large number of cells giving
rapid and reproducible results. Flow cytometry has been
little studied in the gastric mucosa. There are
methodological problems; for example the method depends
upon the preparation of a a single cell suspension - this
is simple for lymphoid tissue but in the case of the
stomach it necessitates grinding and enzymatic
degradation of the tissue. The DNA is then stained,
filtered to remove clumps and syringed to break up small
aggregations. The principle of the flow cytometer is
illustrated in Fig 3:2.
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The stained cell suspension is injected into the flow
cell of the flow cytometer (1) where it is
hydrodynamically focussed (2) to pass through the
interrogation point, excitation taking place in either an
enclosed quartz flow cell or in air (3). The cell
interacts with the laser light (emitted at 488 nm)
scattering it in all directions; light scattered in a
forward direction is related to the size of the cell, and
that at 90 degrees to the amount of refraction of its
internal structure (4). Volume and polarization
measurements are also possible. Analogue electrical
signals are generated for each particle (6) and converted
into digital signals (7) for processing by the computer
software (8) to generate parameter correlated histograms.
Many stains are available (Shapiro et al, 1986). Most
DNA stains will not enter a viable cell and alcohol
fixation or detergent treatment is necessary to render
the plasma membrane permeable (Traganos et al, 1977). In
this study propidium iodide was used: when excited at 488
nm it emits light in the red spectrum at 580 nm. The
intensity of the red light emitted by the excited nuclei
correlates to the amount of DNA in the nucleus. The red
light is sensed by a photomultiplier tube which amplifies
the signal prior to converting it to a digital pulse.
The accumulated pulses from a sample are then used to
generate a histogram (Fig 3:3).
A variety of mathematical methods have been developed for
subdividing DNA histograms into their cell cycle
90
Fig 3:3
Schematic diagram of DNA histogram
from flow cytometer
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components - G0/G1, S, G2/M. All models are held to be
relatively accurate although differences have been
observed. In this study the PARA 1 software was used:
the method assumes a Gaussian distribution of the G0/G1
and G2/M phases and then fits a rectangular model for the
"S" phase. By subtraction of the "S" phase from the
Gaussian distribution, the percentage of events in each





Aspirin-associated gastro-intestinal blood loss was
measured in 10 healthy volunteers aged 22 to 40 years
(mean 31.5 years): none had a history of dyspepsia,
smoking nor took any medications. A 15 ml venous blood
sample was obtained from each subject, the red cells were
labelled with 2.4 MBq of Cr51 and then reinjected into a
vein. The study lasted 5 weeks (fig 3:4), aspirin being
taken during week 1 and week 5. Five subjects were
randomised to aspirin alone on week 1 and the LA/aspirin
combination on week 5; the other 5 received LA/aspirin
in week 1 and aspirin alone during week 5. 1.2g of
soluble aspirin was taken 8 hourly on an empty stomach.
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fig 3:4
























lg of linoleic acid was taken 30 minutes prior to the
aspirin during the combination weeks. All faeces were
collected during week 1 and week 5, separated by a three
week "washout" period. Radioactivity was measured using
a gamma counter and the amount of blood loss was
calculated by reference to the radioactivity of a 10ml,
mid-week sample of venous blood. Linoleic acid was
administered in gelatine-coated capsules containing the
free acid (rather than ester), suspended as a micellar
solution in the non-ionic detergent Pluronic F68.
(ii) Red cell labelling
15 mis of blood were withdrawn and placed in a sterile
universal container with tri-sodium citrate as an anti¬
coagulant and centrifuged at 3000 rpm for 10 minutes. The
plasma and buffy coat were removed (to remove the
leucocytes to which Cr5^ can also bind). 2.4 MBg of
Cr5-*- were added to the red cells in the form of sodium
chromate (12 MBg in 10ml) and incubated at 37 °C for 10
minutes. The blood was washed three times with sterile
saline after centrifuging (to remove any of the unbound
isotope); it was then made up to 15mls with sterile
saline and returned to the patient.
The radioactivity in the blood samples was measured using
an LKB automatic # - counter. All stool samples were
counted in a large (Part body) sample 6 -counter. As
different machines were used for counting, a correction
factor was derived by comparing 0.2 MBq of Cr51 in 200mls
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of chromic chloride: 200mls aliquots were measured in
the large sample counter and 5mls aliquots in the sample
counter.
For experimental blood samples 5mls were taken and
counted in the sample counter for 400 seconds, an empty-
tube was also counted to measure background
radioactivity.
Stool samples were collected in wax cartons and counted
for 400 seconds in the part body counter. Background
counts were also measured.
b) Alcohol study
i) Design
The damaging effects of ethanol upon the gastric mucosa
were assessed in 6 volunteers aged 22 to 38 (mean 26.6)
years. After an overnight fast each subject underwent
routine upper gastrointestinal endoscopy using an Olympus
GIF P10 gastroscope. Intravenous sedation was not
administered although the pharynx was anaesthetised using
Lignocaine spray. Normality of the oesophagus, stomach
and duodenum was confirmed endoscopica1ly and two
biopsies were taken from the gastric antrum. 30 mis of
80% ethanol were then directly infused onto an
accessible, convenient part of the gastric antrum using a
catheter passed through the biopsy channel of the
endoscope. The endoscopic appearances were carefully
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documented 3 and 10 minutes after ethanol infusion and
two biopsies were taken at both time points from the
mucosa around the damaged area. The endoscope was
removed, then reintroduced 30 and 90 minutes after
ethanol for further visual inspection and biopsies.
Each subject was studied on two occasions separated by
two weeks. On one occasion subjects were pre-treated
with 48 hours of linoleic acid, lg 8 hourly, and the
experiment was conducted exactly one hour after ingesting
the last capsule of linoleic acid, whereas on the other
occasion they had no pre-treatment. The subjects were
crossed-over and randomised.
ii) Alcohol-induced mucosal injury was assessed
in the following way
Macroscopic appearances were graded using a method
modified from Agrawal et al (1986)
0 = normal
1 = marked diffuse hyperaemia
2 = single haemorrhage < 2 mm
3 = 2-5 haemorrhages < 2 mm
4 = numerous or confluent lesions
Microscopic changes were assessed using several
techniques - biopsies were processed using standard
histological techniques and stained using haematoxylin
and eosin. The degree of damage was assessed by an
independent histologist (Dr. Alastair Lessels) who had no
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knowledge of the mucosal appearances or timing of the
biopsies. The presence or absence of superficial
erosions and cell necrosis was determined for each
section.
Autoradiography was performed on other biopsies using a
modification of the method described by Hart Hansen et al
(1975). Immediately after the biopsy was taken it was
placed in 2mls of RPMI 1640 cell culture medium (Flow
Laboratories, Irvine, Scotland) at 37° for one minute.
The mixture was gently agitated to remove debris and
mucus. The biopsy was transferred to a fresh solution of
RPMI containing 20ug/ml of ^H-TdR (Amersham
International) at pH 7.4 and incubated for one hour at
37°C. The tritiated medium was poured away and the biopsy
washed in unlabelled RPMI for 10 minutes then fixed in
10% buffered formal saline for 24 hours at room
temperature.
The biopsies were then processed for standard microscopy
using an automatic tissue processor (Histokinette,
British American Optical Co. Ltd.) which passes the
sample through graded alcohols.
Biopsies were embedded in paraffin wax at 50°C, 3um
sections were cut using a Jung rotary microtome,
placed onto Poly-L-lysine-coated slides and dried on a
hot plate at 60°C. From each biopsy at least 6 levels
were cut in both a transverse and a tangential plane.
Photographic emulsion (Ilford K5, Ilford, Essex) was
applied in a dark room. It was mixed with an equal
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amount of glycerine (to dilute and reduce background fog)
and mixed in a water bath at 43°C. The slides were
carefully dipped to ensure even coating, placed in a
dessicator overnight and stored for 4 weeks in a dark
enviroment at 4°C.
The slides were developed by placing them in Kodak D19b
developer for 3.5 minutes followed by washing in water
and then placing in Kodak Unifix at 35°C for 10 minutes.
They were finally washed in tap water for 15 minutes and
then stained with haematoxylin and eosin in a routine
manner. The silver grains due to ^H-TdR autoradiography
were easily counted by light microscopy (fig 3:5). Cells
were considered to be labelled if there were five or more
grains overlying the nucleus. About 40% of slides were
unsuitable for counting for technical reasons: these
included fogging of the slide during development, poor
sectioning or poor orientation. Glands were only
counted if there was at least one labelled cell in the
cross-section, indicating that it was the proliferative
zone. This inevitably meant that there was an over-
estimation of the labelling index (as glands without
labelled cells have not been counted) . This can be
corrected for by a formula devised by Hart Hansen et al
(1975) which is depicted in Fig 3:6.
Background counts of silver grains were estimated by
counting the number of grains over a lymphocyte or the
number of grains over a mitotic figure.
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Nomogram for correction of labelling indices estimated on basis of
cell counts in cross sections of foveolae. p represents the corrected
labelling index, n the mean number of cells in the cross sections,
and L.I. is the actual estimated labelling index.
After Hart Hanson O. et al
Gut. 1975; 16:23-27
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a Leitz Wetzlar Ortholux II microscope calibrated to give
numbers of cell/mm^. On transverse sections (fig. 3:7)
at least 40 eyepiece grids were counted using a 400
magnification and the mean number of labelled cells was
obtained. The frames were orientated with the surface
and included isthmus and neck of the gland.
Accuracy was assessed by counting one slide on 10
different occasions over a 3 month period. This was to
ensure that counting technique and reproducibility were
maintained for the duration of the study. The labelling
index of this slide ranged from 14.9 - 17.0%. The mean
was 16.4% (SEM 0.20). The relative standard deviation
was 6.5%.
Flow cytometry was performed on other specimens taken
from the gastric mucosa. A biopsy was fixed in 98%
methanol for 24 - 72 hours and then ground over wire mesh
to disaggregate the tissue. It was then placed in a
solution of 0.05% porcine pepsin in N Saline (which was
adjusted to pH 1.5 using 2N HC1) and allowed to react
for 30 minutes at 37°C. It was vortexed at 10 minute
intervals, washed twice in phosphate-buffered saline
containing 1 % bovine albumin (to halt the pepsin). This
solution was filtered through washed nylon wool, and re-
suspended in staining solution (containing propidium
iodide 50ug/ml, 0.1M hypotonic TRIS, 5mmol MgCl, lmg/ml
ribonuclease). Counting was performed using a Coulter










a) Aspirin-induced blood loss
All tolerated the large dose of aspirin well although
most had epigastric discomfort initially. Faecal blood
loss was significantly elevated in all volunteers while
taking aspirin and fell during the "washout" period. Mean
blood loss was 36.6 (± 5.8) mis/week when aspirin alone
was taken (tab 3:1). It was almost identical at 34.7 (±
6.5) mis/week in the week when aspirin and linoleic acid
were taken together (fig 3:8).
b) Alcohol-induced injury
All the subjects tolerated these experiments remarkably
well. Repeated endoscopies were easily accomplished and
alcohol infusion caused no symptoms.
i) Endoscopic appearances
Alcohol infusion was almost immediately followed by
erythema and mucosal oedema. By 90 minutes petechial
haemorrhages and superficial erosions were seen (fig
3:9). The endoscopic appearances were similar whether or




FAECAL BLOOD LOSS (ml / week) CAUSED BY ASPIRIN















VISUAL SCORING OF DAMAGE TO THE GASTRIC











ASPIRIN INDUCED INJURY - RESULTS
Mean Faecal Blood Loss with Aspirin alone
and Aspirin with Linoleic Acid
Fig 3:9
MACROSCOPIC DAMAGE TO THE GASTRIC MUCOSA
CAUSED BY 80% ALCOHOL
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ii) Histological changes
The effect of alcohol on the mucosa was assessed in 2
ways histologically:- a) damage to the epithelium and b)
cellular necrosis. The biopsies were all small (because
many were taken and a paediatric endoscope was used) so
only gross changes could be accurately measured. After
the alcohol, the surface epithelium was scored as either
intact (I) or damaged (D). Cellular necrosis was graded
as: -
0 = no necrosis
1 = necrosis at edge, or superficial necrosis
2 = generalised or deep necrosis.
Results are shown on Tab 3:3 and Tab 3:4. Some of the
biopsies showed no apparent damage to the epithelium
after the alcohol, although visible damage had indeed
been caused. This is probably due to the fact that the
biopsies were taken from the edge of the lesion and may
in some cases have missed the damaged area. Examples of
the range of mucosal damage are shown in fig 3:10.
Similarly, cellular necrosis was not always seen,
probably for the same reason.
There was no significant difference in terms of
pathological damage following alcohol before or after the
administration of linoleic acid (p > 0.05).
iii) Autoradiography
The labelling indices were measured in tangential and
transverse sections of the biopsies. The tangential
107
table 3:3
PATHOLOGICAL GRADING OF MUCOSAL INJURY
AFTER ALCOHOL ADMINISTRATION , BEFORE
AND AFTER LINOLEIC ACID
EFFECT ON SURFACE EPITHELIUM
BEFORE LA
VOLUNTEER 0 3 10 30 90
1 I I I D
2 I I I D I
3 D D I D I
4 I I D I I
5 I I D I I
6 I D I D I
AFTER LA
VOLUNTEER
0 3 10 30 90
1 I I I I
2 D I D D I
3 I I I D I
4 I D I D D
5 D I I I I





PATHOLOGICAL GRADING OF MUCOSAL INJURY
AFTER ALCOHOL ADMINISTRATION , BEFORE
AND AFTER LINOLEIC ACID
EFFECT ON CELL NECROSIS
BEFORE LA
VOLUNTEER
0 3 10 30 90
1 1 0 1 1 ...
2 1 1 1 1 2
3 1 1 0 1 0
4 1 1 1 1 1
5 0 0 1 2 1
6 0 1 1 0 1
AFTER LA
VOLUNTEER
0 3 10 30 90
1 0 1 0 0
2 2 1 2 1 1
3 0 0 1 1 1
4 2 1 0 1 1
5 1 2 1 0 1
6 1 1 1 1 0
0 = no necrosis
1 = necrosis at edge or superficial
2 = generalised or deep necrosis
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Fig 3:10
HISTOLOGICAL SECTIONS THROUGH THE GASTRIC
MUCOSA SHOWING PROGRESSIVE MUCOSAL
DAMAGE CAUSED BY 80% ALCOHOL
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sectioned results are shown in table 3:5 and Fig 3:11;
the transverse-sectioned results are shown in table 3:6
and Fig 3:12. Following alcohol infusion there was a
significant fall in the mean labelling index (p < 0.05)
which gradually returned to the basal values over the 90-
minute period. Results were very similar irrespective of
linoleic acid pre-treatment.
iv) Flow cytometry
The results are presented in table 3:7 and fig 3:13. The
mean values are similar to those obtained from
autoradiography. The mean % of cells in "S" phase
(determined by flow cytometry) did not change
significantly after ethanol, and results were similar
whether or not linoleic acid was administered.
Reproducibility of the histograms with 2 x 10^ cells was
excellent. The coefficient of variation range from 2.49-
3.96 (mean 3.23).
4. DISCUSSION
a) Aspirin-induced blood loss
c 1
The main methodological criticisms of using Cr are
that it involves radio-labelling of a patient's blood,
the collection of all their stools and there is no way of
determining where the bleeding is coming from within the
gastro-intestinal tract (Hunt and Frantz, 1981). However
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table 3:5
RESULTS FROM AUTOGRAPHY — LABELLING INDEX





0 3 10 30 90
1 pre LA 18.2 19.7 18.2 15.7
post LA 18.3 15.6 18.9 18.7 —
2 pre LA 14.7 16.5 16.3 10.3 19.9
post LA 15.4 15.7 12.8 12.1 19.5
3 pre LA 18.4 14.8 15.4 12.9 18.3
post LA 20.5 22.7 20.1 17.8 17.0
4 pre LA 16.5 16.5 15.1 14.7 15.6
post LA 19.7 19.4 16.7 16.8 18.8
5 pre LA 19.8 12.9 14.2 15.5 19.1
post LA 17.7 15.3 19.1 15.3 16.3
6 pre LA 18.6 16.8 14.6 13.4 17.1
post LA 13.4 10.3 10.3 13.0 13.1
mean pre LA 17.7 16.2 15.6 13.7 18.0




Labelling Index (LI) of gastric mucosa after alcohol infusion.




RESULTS FROM AUTOGRAPHY — LABELLING INDEX
(as cells / mm2" ) IN TRANSVERSE SECTION OF SLIDE
TIME FROM ADMINISTRATION OF
VOLUNTEER ALCOHOL ( min )
0 3 10 30 90
1 pre LA 104 257 191 195 ...
post LA 236 139 129 149 —
2 pre LA 181 224 198 183 299
post LA 87 124 110 81 174
3 pre LA 272 416 122 172 263
post LA 341 366 329 292 486
4 pre LA 197 152 136 121 102
post LA 261 284 267 86 363
5 pre LA 288 61 94 77 146
post LA 351 260 314 347 311
6 pre LA 164 266 121 174 113
post LA 82 91 53 74 74
mean pre LA 201 229 113 153 184









RESULTS FROM FLOW CYTOMETRY — % OF CELLS
IN " S" PHASE OF CELL CYCLE
TIME FROM ADMINISTRATION OF
VOLUNTEER ALCOHOL (min)
0 3 10 30 90
1 pre LA
post LA
2 pre LA 14.7 25.2 14.5 16.6 25.5
post LA 9.3 5.7 9.4 4.1 14.4
3 pre LA 23.3 20.1 14.2 26.8 19.4
post LA 14.4 21.8 12.4 17.5 19.4
4 pre LA 13.9 6.3 6.1 2.7 10.1
post LA 20.4 19.2 16.7 14.9 12.7
5 pre LA 16.2 24.7 24.4 24.7 15.5
post LA 18.6 12.9 19.0 15.1 20.1
6 pre LA 10.3 8.7 11.3 12.4 12.4
post LA 15.1 12.2 18.1 12.1 26.0
mean pre LA 15.6 16.9 14.0 16.6 16.6




% cells in 'S' phase in the gastric mucosa after alcohol infusion.
Before and after supplementation with linoleic acid (LA)
Time (mins)
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aspirin can cause bleeding throughout the gut and this
can be reduced by orally administered prostaglandin
analogues.
This study showed no reduction of blood loss when
linoleic acid was given prior to aspirin. This was a
little surprising as Cohen et al (1985) demonstrated a
significant reduction in blood loss when aspirin was
taken with Misoprostol (a prostaglandin analogue).
Mean blood loss in the Misoprostol group was 3.75 ml per
day compared to 6.05 ml per day in the placebo group.
Similar reduction of aspirin-induced bleeding was also
found with the PGE2 analogue Enprostil. (Hawkey et al,
1986; Stiel et al, 1986). Enprostil reduced blood loss
from a mean of 7.7 ml/10 minutes when aspirin alone was
taken to 4.2 ml/10 minutes when Enprostil was taken prior
to the aspirin.
The experiments described in Chapter 2 demonstrated a
three-fold increase in PGE output following dietary
supplementation with linoleic acid in normal subjects. It
is not clear why this did not protect against aspirin.
The findings are however supported by Pritchard P et al
(1988) who found an increase in immunoreactive PGE2 after
dietary supplementation with evening primrose Oil
(Efamol) which contains approximately 72% of linoleic
acid (by weight). They also found that aspirin induced
micro-bleeding was not affected by the increase in PGE2.
Mean blood loss from gastric washings after a five-day
1 1 8
course of aspirin was 10.7 ul/10 minutes and 9.4 ul/10
minutes when Efamol was taken prior to the aspirin.
One explanation for the lack of protection from aspirin
relates to the dose of linoleic acid used in these
experiments. The output of PGE occurring after linoleic
acid is at least one order of magnitude less than that
following ingestion of exogenous PGE or one of its
analogues. It may well be that higher doses of linoleic
acid might have led to higher PGE outputs and
demonstrable protective effects. However, such high doses
would cause unacceptable side effects, particularly
diarrhoea.
A further reason for the lack of protection from aspirin
associated blood loss is that aspirin inhibits cyclo-
oxygenase enzymes, interrupting PGE synthesis.
Consequently the anticipated increase in PGE secretion
following linoleic acid might not have occurred. The
design of this experiment precluded measurement of
gastric PGE output and this possibility remains unproven.
It was hoped however that the stimulating effect of
linoleic acid upon prostaglandin synthesis would have
competed with the aspirin effect, and reduce mucosal
damage. Studies in rodents, reported by Konturek et al
(1982) suggest that this was likely to be a vain hope.
In a series of experiments this group showed that
although "adaptive cytoprotection" protected against the
damaging effects of ethanol and 25% NaCl, it had no
1 1 9
effect upon aspirin-associated gastric mucosal injury,
b) Alcohol induced injury
There are several possible explanations to account for
the apparent failure of linoleic acid to protect against
the damaging effects of ethanol on the gastric mucosa.
(i) The output of prostaglandins associated with
linoleic acid may have been insufficient.
(ii) Biopsies were taken from the edge of the damaged
area rather than the centre in order to prevent biopsy
artefact.
(iii) Much of the metabolic evidence cited to support a
role for essential fatty acids in peptic ulcer disease is
derived from studies of experimentally induced ulcers in
rats, in which either ethanol or aspirin were used to
induce the gastric lesions (Hollander et al, 1982;
Tarnawski et al, 1985). Both these agents inhibit - 6
desaturase, the rate limiting enzyme for the conversion
of linoleic acid to arachidonic acid. Therefore the
beneficial effects of the administration of these acids
may be nullified by the presence of aspirin and alcohol
(Huang et al, 1987; Wang and Reitz, 1983).
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c) Linoleic acid and endogenous gastric prostaglandin
secretion
Although it is widely accepted that orally administered
(exogenous) prostaglandins and their analogues protect
the stomach, the role of prostaglandins secreted by the
stomach (endogenous prostaglandins) is less well
understood. Endogenous prostaglandins have been studied
in several ways -
(i) Inhibiting the formation of prostaglandins by NSAIDS.
Although NSAIDS do inhibit cyclo-oxygenase enzymes and
are associated with gastric mucosal injury, it does not
necessarily follow that these effects are related.
(ii) Adaptive cytoprotection. This is the phenomenon
whereby low doses of a damaging agent protect the gastric
mucosa from higher doses of the same or another toxin.
It is extremely indirect evidence for a role of
endogenous prostaglandins since other factors may also
be responsible.
The observation that linoleic acid increased gastric
prostaglandin output whereas saturated fat did not,
provides the basis of a much more "physiological"
approach to the study of endogenously secreted gastric
prostaglandins. This concept had previously been
employed by others in experimental animals but no
previous workers had studied man. Schepp et al (1988)
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studied groups of rats whose diets were depleted or
supplemented with linoleic acid. Linoleic acid-depleted
diets were associated with markedly reduced PGE output
and increased basal and maximal acid output. Damage
induced by cold and restraint was increased compared to
rats given normal diets. In contrast, rats with high
linoleic acid diets exhibited increased PGE output,
decreased acid secretion and decreased gastric mucosal
injury. Tarnawski et al (1985) studied groups of rats
whose diets were supplemented with Pluronic F68, oleic
acid or two doses of linoleic acid (in Pluronic F68).
100% ethanol was infused into the stomach one hour after
the last dose of fatty acid or solubiliser. In the two
control groups histology and E-M revealed that more than
90% of the surface epithelium had been damaged and visual
necrosis occupied 40-70 % of the surface area. In the
two linoleic acid treated groups, histology and
E-M revealed significantly reduced disruption of the
surface epithelium (8%) and necrosis was visible over
only 3-9% of the surface area. This protection only
occurred if the linoleic acid was given intragastrically
(and not when given intrajejunally) and gave rise to an
increase in PGE output. In a similar series of
experiments in rats the same group (Hollander D et al
1982) looked at the effect of arachidonic acid (AA) on
mucosal protection against alcohol injury. They looked
at the effects of alcohol on mucosal histology, E-M,
mitotic index, H-TdR, pH and electrolytes and mucosal
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potential difference. They found that mucosal necrosis
was a time-related process: those rats receiving
arachidonic acid had less mucosal injury, less severe
disruption of mitosis, the labelling index was higher,
potential difference and pH recovered more quickly.
It is possible that endogenous prostaglandins, stimulated
by linoleic acid, protect the human stomach but
discernable benefits of linoleic acid were not found
from the studies described in this chapter.
d) Comparison of flow cytometry with autoradiography
The mean values for the labelling index obtained from
flow cytometry (15.6 %) mirrored those from auto¬
radiography (17.7 %). Autoradiography is a reproducible
and recognised technique whereas flow cytometry applied
to gastric tissue is still being developed. Difficulties
occur in preparing cell suspensions for flow cytometry
and this can lead to problems of reproducibility. For




DIETARY LINOLEIC ACID, GASTRIC PROSTAGLANDINS AND
DUODENAL ULCER
1. INTRODUCTION








As briefly discussed in chapter 1, there has been a
decline in the incidence and virulence of peptic ulcer
disease throughout the West (Mendeloff, 1974; Bonnevie,
1985) during this century. This is based upon a number
of observations:-
i) There has been a gradual decline in hospital
admissions over the last few decades (Elashoff and
Grossman, 1980; Brown et al, 1976). This may be a
reflection of decreasing incidence, a change in the
severity of the disease or may be due to revised criteria
for admission; peptic ulcer patients are now mainly
treated as out-patients.
ii) There has been a decline in the incidence of
perforated peptic ulceration (MacKay, 1966; Illingworth
et al, 1944; Jamieson, 1955). This is a good index of
virulence because all the patients are hospitalised.
Perforation occurs in only a minority of ulcer patients -
between 5 and 10% (Litton and Murdoch, 1963) and about
70% of perforations occur in patients without a
preceeding history of peptic ulcer disease (Cassel,
1969 ) .
iii) Prospective studies of the prevalence and
epidemiology did not appear until 1950. These show
considerable differences between countries and even
within countries. In the United Kingdom the incidence of
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duodenal ulcer increases as one travels northwards
(Langman, 1979). A prospective study of first-time
diagnosed cases of duodenal ulcer in males in New York
city showed a significant fall over the years 1952 -
1963 (Pulvertaft, 1959; Pulvertaft, 1968). In Iceland
Jonasson (1983) noted a less marked decline.
The factors associated with this falling incidence and
virulence have been widely studied. These include
powerful new ulcer healing drugs, a decline in smoking,
enviromental factors including industrialisation, changes
in work patterns, climate (Kurata and Haile, 1984;
Friedman et al 1974) and changes in diet.
Ulcer healing drugs have been available since the late
1970's and their use has been associated with a marked
fall in the number of operations performed for
uncomplicated peptic ulcer. These drugs do not affect
the development of an ulcer but they do induce a
temporary remission. The falling incidence of peptic
ulcer disease pre-dated the introduction of these new
agents.
Cigarette smoking is associated with a decrease in ulcer
healing (Sontag et al, 1984) and may be associated with
the development of ulcers. The recent decline in
smoking in the U.K. cannot be held responsible for this
long-term trend.
People from social class V have a higher incidence of
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peptic ulcer disease than those in social class I. The
reasons are not known but may be related to environment,
differences in smoking, diet and recreation.
While general improvement in nutrition could be
relevant, it is conceivable that changes in specific
dietary components could affect ulcer epidemiology.
This thesis has shown that changes in dietary essential
fatty acid consumption are associated with an alteration
in the output of gastric prostaglandins and these have
effects upon acid secretion and mucosal protection.
Hollander and Tarnawski (1986) suggested that the
observed 200% increase in linoleic acid consumption could
account for the falling incidence and virulence of peptic
ulcer. This chapter explores this hypothesis by
comparing the fatty acid composition of adipose tissue
obtained from duodenal ulcer and matched control
patients.
Estimates of dietary intakes of linoleic acid are
unreliable because of the paucity of data on the fatty
acid composition of common foodstuffs and because of the
inaccuracies inherent in the short term assessment of
nutrient intakes in general (Roshanai and Saunders, 1984;
Black, 1986). In contrast, adipose tissue levels of
dietary linoleic acid accurately predict long-term
intakes of dietary linoleic acid and have been used in
many epidemiological and case control studies which
examined the link between dietary intakes of linoleic
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acid and coronary heart disease (Van Staveren et al,
1986; Fordyce et al, 1983; Wood et al, 1987).
The aims of this study were :-
i) To compare adipose linoleic acid and fatty
acid profiles in duodenal ulcer and control
patients.
ii) To determine whether the linoleic acid
composition of adipose tissue bears any




Thirty five men with endoscopically proven chronic
duodenal ulcers aged 21 - 79 years (mean 45) were
studied. All had a long dyspeptic history but none had
undergone surgery or was taking non-steroidal anti¬
inflammatory drugs or any ulcer-healing medications at
the time of the study. Each ulcer patient was matched
with a control male subject of similar age, social
class, and smoking history. The control subjects
comprised patients undergoing routine minor elective
surgery (principally inguinal hernia repair and
haemorrhoidectomy) and laboratory personnel. None of the
controls had a history of dyspepsia or were taking any
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drugs. Their ages ranged from 18 - 75 years (mean 46).
Non-smoking was defined as never having smoked or
having stopped for at least 6 months before the study;
current smokers were matched for their daily cigarette
consumption.
Adipose Tissue Sampling and Laboratory Analysis
Adipose tissue was sampled from the anterior wall: 2-3
mis of 1% lignocaine with adrenaline were first injected
sub-cutaneously, and a 3 mm diameter Stieffel skin biopsy
needle was then used to core out the skin and sub¬
epidermal fat. A small quantity of fat (no greater than
20 mg) was required for analysis. The fat was separated
from the skin, rinsed with saline, dried on absorbant
paper and stored in an Eppendorf container at -60°C.
Samples were assayed in a blind manner using the
chromatographic method described by Wood et al (1987).
Adipose tissue samples were thawed, rinsed in saline and
the lipids were extracted into re-distilled heptane. The
extract was washed with isopropanol/0.05% potassium
hydroxide by volume, in order to remove non-esterified
fatty acids and phospholipids. The neutral lipid extract
was reduced to dryness under vacuum then dissolved in dry
toluene. Fatty acid methyl-esters were prepared by
direct transmethylation (10 min at 50°C with 0.5 mol/1
sodium methoxide in methanol). The fatty esters were
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washed with acidified water and re-extracted into hexane:
the hexane layer was evaporated under vacuum. The methyl
esters were redissolved in 40 ul redistilled chloroform,
ready for analysis on a Pye Chromatograph 204, fitted
with a 1.5 m column, packed with GP 10%, SP-2330 on
100/120 mesh Chromosorb W AW (Supelco). The peaks were
quantified with a flame ionisation detector and "Tri-
vector III" integrator. The methyl-ester peaks in the
chromatograms were identified by a combination of
argentation thin layer chromatography (TLC) and
comparison of retention times with those of authentic
fatty-acid esters (Pufa 1 and 2 and NIH mixtures,
Supelco). For complex peaks, GC/MS was used in a few
random samples. A typical TLC printout is shown in
Fig 4:1.
Gastric secretion studies
Thirteen ulcer subjects and seven controls underwent a
pentagastrin secretion test. The method has been
described in chapter 2. Gastric acid output was
determined in 5 ml aliquots of gastric juice by titration
to pH with 0.01 N NaOH using a N82 standard pH meter
(Radiometer, Copenhagen). Gastric acid output was
calculated from the product of concentration and volume.
Basal output was derived from the juice collected before
the pentagastrin and maximal acid output from the juice
collected after the pentagastrin had been given.
Prostaglandin output was measured from the gastric juice
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Fig 4:1
Example of thin layer chromatography ( TLC )
of fatty acid profile from adipose tissue
Appendix 4:1
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by the method previously described in Chapter 2. Output
was calculated from the product of concentration and
volume.
3. RESULTS
The % linoleic acid in the adipose tissue was
significantly lower in the ulcer group when compared to
the controls, and this was true for both smokers and non-
smokers (Table 4:1). Wood et al ( 1987) also found that
adipose fatty acid profile between smokers and non-
smokers was different. There was no significant
difference in the profiles of the other fatty acids
between the 2 groups (tab 4:2).
Table 4:3 depicts the mean % linoleic acid in adipose
tissue, prostaglandin and acid secretory status of the 7
control and 13 ulcer subjects who underwent the modified
pentagastrin test. In the ulcer patients there was no
relationship between % linoleic acid in adipose tissue
and gastric PGE output ( r = 0.003), PGEM output (r =
0.04), basal or stimulated acid secretion (r = -0.02 and
0.13 respectively).
In control subjects there was no relationship between %
linoleic acid in adipose tissue and PGE and PGEM output
(r = 0.03 and 0.04 respectively), but % linoleic acid in
adipose tissue and basal acid output were significantly
negatively correlated (r = -0.74, p < 0.01). The
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table 4:1
LINOLEIC ACID COMPOSITION OF ADIPOSE
TISSUE ( % composition W / W )
NON
OVERALL SMOKERS






9.9 + 0.68 9.4 + 0.59 10.8 ± 0.72
35 14 21
12.3 + 0.75 12.1 +0.85 12.4 + 0.93
table 4:2
MEAN VALUES OF ADIPOSE TISSUE FATTY






palmitic acid (16:0) 22.7 + 0.55 21.9 + 0.34
palmitoleic acid (16:1) 6.1 ±0.28 7.9+0.28
stearic acid (18:0) 4.8 + 0.26 4.0 + 0.16
Oleic acid (18:1) 47.1 +0.48 47.7 + 0.78
LINOLEIC ACID(18:2) 12.3 + 0.75 9.9 + 0.68
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Tab 4:3
Comparison of mean values of % linoleic acid in
adipose tissue with mean values of PGE output,
basal acid output ( BAO) , and maximal acid











n = 7 12.8 ( 1.1) 614 (101) 4.5(1.3) 29.4 (4.5)
DU
patients 11.0 (1.3) 89 ( 14) 3.2 (0.5) 30.8 (3.7)
n = 13
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relationship between % linoleic acid in adipose tissue
and basal acid output is shown in Fig 4:2. Adipose %
linoleic acid and maximal acid output were also inversely-
related (r = -0.58, p < 0.05 ): this is illustrated in
Fig 4:3.
DISCUSSION
The study has shown that mean dietary linoleic acid
intake was lower in male duodenal ulcer patients than in
control subjects of similar age, smoking habits and
social class. These findings are consistent with the
hypothesis that dietary essential fatty acids influence
the natural history of duodenal ulcer.
Although there was no relationship between % linoleic
acid in adipose tissue and gastric prostaglandin output,
it is likely that the effect of linoleic acid upon ulcers
is mediated through prostaglandins. Gastric
prostaglandin output is a crude reflection of
intracellular events and it is possible that subtle
changes in prostaglandin metabolism result in changes of
mucosal protection and acid secretion. Of interest is
the significant negative relationship observed between %
linoleic acid in adipose tissue and acid secretion which
was only seen in control subjects. In Chapter 2 it was
shown that in normal subjects dietary linoleic acid
increased gastric prostaglandin secretion and suppressed
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Fig4:2RELATIONSHIPOFADIPO ETISSU%L N LE CCIDNB ALA IOUTPUT(BAO)INHEALTHYCO TROLS %LINOLEICACIDDIPOSETISSU
Fig4:3




acid output, but this did not occur in patients with
duodenal ulcer. It may therefore be that normal
subjects can protect their gastric mucosa by consuming
essential fatty acids. This does not occur in duodenal
ulcer because these patients do not respond to dietary
linoleic acid by increasing gastric prostaglandin
secretion. From this study it is not clear whether the
lower % linoleic acid found in the adipose tissue of
duodenal ulcer subjects may be a factor in the aetiology
of their duodenal ulcer disease, or whether it is due to
a change in their diet as a result of their dyspepsia. It
is unlikely to be the latter as many medicines and









During the course of this study several interesting facts
have emerged. Linoleic acid administered orally in
modest doses gave rise to a significant increase in the
output of PGE and PGEM in normal healthy controls. This
is a specific feature of linoleic acid and not merely a
non-specific effect of fatty acids, because controls
given a saturated fatty acid stearic acid (which is
not a prostaglandin precursor) had no effect on PGE and
PGEM output. This dietary stimulation of endogenous PGE
is an immediate effect which wanes rapidly over 1 hour.
In patients with proven duodenal ulcer disease gastric
PGE output was much lower than that found in controls and
did not increase in response to linoleic acid. More of
the prostaglandin was found as its metabolite 13,14-
dihydro 15-keto PGE2• This suggested that there is a
difference in the handling of dietary prostaglandin
precursors in duodenal ulcer subjects and that
prostaglandin catabolism is increased.
This difference in PGE output was mirrored by the change
in acid output after linoleic acid administration. In
the controls, but not in the ulcer patients, gastric
acid output was significantly decreased by dietary
linoleic acid. The reduced acid secretion in the control
group was probably secondary to the significant rise in
gastric PGE secretion.
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A difference was also found in the concentration of serum
gastrin after linoleic acid. In the normal subjects,
there was a significant increase in serum gastrin
concentration after linoleic acid. This did not occur
in the control group taking stearic acid nor in the
duodenal ulcer group. It is difficult to explain this
difference. A rise in gastrin is found in people taking
acid reducing drugs (e.g. H2 blockers), however in this
study acid suppression was fairly modest and therefore
unlikely to be the reason for the increase.
Orally administered (exogenous) prostaglandins have
been shown to protect the gastric mucosa from many
types of injurious agents, however the importance of
locally secreted prostaglandins is less well understood.
Most of the evidence for a role of endogenous
prostaglandins is indirect and comes from the phenomenon
of "adaptive cytoprotection".
In this study an alternative approach to the
investigation of the protective effects of endogenous PGE
was adopted - namely the stimulation of endogenous PGE by
linoleic acid. Three approaches were used to study the
protective effect of endogenous PGE - mucus output,
aspirin-induced injury and alcohol-induced injury.
Dietary linoleic acid increased mucus output in controls
but not in duodenal ulcer subjects.
Exogenous prostaglandins and their analogues are known to
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protect the stomach from injury by both aspirin and
alcohol but in this study linoleic acid had no such
effect. This may be a dose related phenomenon, the levels
of endogenous PGE found in this study were much lower
than the doses of exogenous PGE administered in other
studies. It could also be that both aspirin and alcohol
prevented the anticipated rise in gastric prostaglandin
secretion following linoleic acid.
At a cellular level no increase in protection after
stimulation of endogenous PGE was found - in contrast
with the effect of exogenous PGE. This again, could be
a dose-related phenomenon.
Overall it was found that the induction of PGE had no
significant beneficial effect in the models of injury
that were studied.
Adipose tissue linoleic acid levels, which reflect
chronic dietary habits, were significantly lower in
duodenal ulcer patients than in matched control
subjects. This difference occurred in smokers and in non-
smokers. In the healthy controls, but not in the ulcer
patients, there was a significant negative correlation
between gastric acid secretion and the % linoleic acid in
adipose tissue. No relationship was found between %
linoleic acid in adipose tissue and gastric prostaglandin
secretion in either group.
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2. CONCLUSION
The thesis set out to examine the hypothesis of Hollander
and Tarnawski that the natural history of duodenal ulcer
could have been influenced by changes in dietary
essential fatty acid intake. The evidence derived from
these studies partly supports this contention and
provides further insight into prostaglandin metabolism in
duodenal ulcer disease.
While gastric prostaglandin secretion was not increased
in duodenal ulcer subjects receiving linoleic acid, the
observation that normal subjects did exhibit this
response, coupled with a fall in gastric acid secretion
in these individuals, suggests that linoleic acid can
maintain a benign gastro-duodenal environment in normal
subjects. In ulcer patients dietary linoleic acid had no
effect on gastric secretion and there was no advantage in
taking the fatty acid. This is reflected in the
differences in adipose fatty acid profiles in the control
and ulcer groups. Duodenal ulcer patients take less
linoleic acid in their diet. This may be of aetiological
significance in peptic ulcer disease.
The reasons for the different handling of linoleic acid
between healthy controls and ulcer patients cannot be
answered by the data presented in this thesis. The low
secretion of PGE and the relatively high levels of PGEM
in the ulcer group suggest increased PGE catabolism
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rather than a failure of PGE synthesis. On the other
hand the lack of increase in PGE output following
linoleic acid suggests an additional defect in the
incorporation of linoleic acid into the prostaglandin
cascade. Only further studies involving incubation of
biopsies could clarify the situation.
The role of endogenous PGE in protection of the gastric
mucosa from injurious agents is inconclusive. While
exogenous PGE appears to be protective, endogenous PGE in
this study showed few beneficial properties.
3. WHAT IS NEW ?
This research has highlighted several new aspects to
duodenal ulcer disease.
It has demonstrated a different way of studying
endogenous prostaglandins.
It has demonstrated a method of stimulating
endogenous prostaglandins using linoleic acid in
its free fatty acid form.
It has highlighted differences in gastric
physiology between normal controls and patients
with duodenal ulcer. The two groups respond
differently to linoleic acid in terms of their
PGE output, gastric acid secretion, mucus output
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and fasting serum gastrin concentration.
It has helped to clarify some of the conflicting
results in the literature regarding prostaglandin
output in health and in duodenal ulcer disease.
It has contrasted the dramatic effects of
exogenous prostaglandins as reported in the
literature with the modest effects of endogenous
prostaglandins.
It has demonstrated that duodenal ulcer patients
take less linoleic acid in their diet than
healthy controls.This may be another aetiological
factor in peptic ulcer disease.
It has utilised new techniques in radioimmuno¬
assay which improve its sensitivity and
specificity - namely using methyloximated
derivatives.
It has contrasted several complementary
methods of assessing mucosal injury - empirically
by measuring aspirin-induced blood loss, and at a
cellular level by autoradiography and the
relatively new technique of flow cytometry.
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4. THE WAY AHEAD
It would be useful to pursue this avenue of research
further.
i) To investigate whether much larger doses of
linoleic acid could reduce aspirin-induced
bleeding and alcohol-induced injury.
ii) To perform more extensive dose-related studies
into linoleic acid and PGE output.
iii) To investigate further the differences
between the control group and the
ulcer patients - to demonstrate why there
there should be a block in utilising linoleic
acid in the ulcer patients and at what level
this occurs; to find out why there should be
increased metabolism of PGE in the ulcer
patients.
iv) To perform a larger epidemiological study on
the dietary intake in the two groups.
1 46
REFERENCES
Agrawal NM, Bodiwala T, Arimura A, Dajani E (1986)
Cytoprotection by a synthetic prostaglandin against
ethanol-induced gastric mucosal damage. Gastrointest
Endosc 32(2):67-70
Aherne W, Camplejohn RS, Wright NA (1977) An
introduction to cell population kinetics. Edward Arnold,
London, 20-39.
Ahlguist DA, Duenes JA, Madson TH, Romero JC et al
(1982) Prostaglandin generation from gastroduodenal
mucosa : regional and species differences. Prostaglandins
24 :115-125
Ahlguist DA, Dozois RR, Zinsmeister AR, Malagelada JR
(1983) Duodenal prostaglandin synthesis and acid load in
health and in duodenal ulcer disease. Gastroenterology
85:522-528.
Bahari HMM, Ross IN, Turnberg LA (1982) Demonstration of
a pH gradient across the mucus layer on the surface of
human gastric mucosa in vitro. Gut 23:513-516.
Bardhan KD, Whittacker L, Hinchcliffe RFC, Cleur K et al
(1984) Trimoprostil vs cimetidine in duodenal
ulcer. Gut 25:A580.
Baron JH, Barr J, Batten J, Sidebotham R et al (1986)
Acid, pepsin and mucus secretion in patients with gastric
1 4 7
and duodenal ulcer before and after colloidal bismuth
subcitrate (De-nol). Gut 27:486-490.
Bennett A, Murray JG, Wyllie JH (1968) Occurrence of
prostaglandin E2 in the human stomach, and a study of
its effects on human isolated gastric muscle. Br J
Pharmacol Chemother 32:339-349.
Bennett A, Stamford IF, Stockley HL (1977) Estimation
and characterisation of prostaglandins in the human
gastro-intestinal tract. Br J Pharmacol 61:579-586.
Bergstrom S, Sjovall J (1960) The isolation of
prostaglandin E from sheep prostate glands. Acta Chem
Scand 1701-1705.
Black AE (1986) The use of recommended daily allowances
to assess dietary adeguacy. Proc Nutr Soc 45:369-381.
Bolton JP, Palmer D, Cohen MM (1978) Stimulation of
mucus and non parietal cell secretion by the E2
prostaglandins. Am J Dig Dis 23:359-364.
Bonnevie 0 (1985) Changing demographics of peptic ulcer
disease. Dig Dis and Sci 30 (11) Suppl:85-145.
Bowen JC, Kuo Y-J, Pawlik W, Williams D et al ( 1975)
Electrophysiological effects of burimamide and 16,16
dimethyl prostaglandin E2 on the canine gastric mucosa.
Gastroenterology 68:1480-1484.
Boyes BE ,Crean GP, Watkinson G (1971) Studies in the
1 48
rates of epithelial cell exfoliation from gastric mucosa
in normal and ulcer subjects. Gut 12:867.
Brodie DA, Chase BJ (1967) Role of gastric acid in
aspirin-induced gastric irritation in the rat.
Gastroenterology 76:88-93
Broughton-Smith NK, Vane JR, Whittle BJK (1978) Effects
of prostacyclin (PGI2), PGI-^, and 6-oxo-PGF^o^ on the rat
gastric mucosa. Br J Pharmacol 62:413.
Brown RC, Langman MJS, Lambert PM ( 1976 ) Hospital
admissions for peptic ulcer during 1958-1972. Br Med J
1: 35-37.
Bugat R, Thompson M, Aures D, Grossman MI (1976)
Gastric mucosal lesions produced by intra-venous infusion
of aspirin in cats. Gastroenterology 71:754-759.
Cairnie AR, Lamerton LF, Steel GG (1965a/1965b) Cell
kinetic proliferation studies in the intestinal
epithelium of the rat. I. Determination of the kinetic
parameters. Exp Cell Res 39:528-538. II. Theoretical
aspects. Exp Cell Res 39:539-553.
Cassel P (1969) Perforated duodenal ulcer in Reading
from 1950 to 1959. Gut 10:454-459.
Chaudhury TK, Jacobson ED (1978) Prostaglandin
cytoprotection of gastric mucosa. Gastroenterology 74:
58-63.
1 49
Cheung LY, Jubiz W, Moore JG (1976) Gastric
prostaglandin E output during basal and stimulated acid
secretion in normal subjects and patients with duodenal
ulcer. J Surg Res 20:369-372.
Classen M, Koch H, Bickhardt J, Topf et al (1971) The
effect of prostaglandin E-^ on the pentagastrin stimulated
gastric secretion in man. Digestion 4:333-344.
Cohen MM (1975) Prostaglandin E2 prevents gastric
mucosal barrier damage. Gastroenterology 68:A-19/876.
Cohen MM, Clark L, Armstrong L, D'Souza J (1985)
Reduction of aspirin-induced faecal blood loss with low
dose Misoprostol tablets in man. Dig Dis and Sci
30(7):605-611.
Crampton JR, Gibbons LC, Rees WDW (1987) Simultaneous
measurement of in vitro gastroduodenal prostaglandin E2
synthesis and degradation in peptic ulcer disease. Scand
J Gastroenterology 22:425-430.
Crawford MA (1983) Background to essential fatty acids
and their prostanoid derivatives. Br Med Bull 39:210-
213 .
Dekanski JB, MacDonald A, Sacra P, Parke DV (1975)
Effects of fasting, stress and drugs on gastric
glycoprotection synthesis in the rat. Br J Pharmacol
55 : 387-392.
Domschke S, Domschke W (1984) Gastroduodenal damage due
150
to drugs , alcohol and smoking. Clin Gastroenterol
13: 405-436.
Domschke W, Domschke S, Hornig D, Demling L (1978)
Prostaglandin-stimulated gastric mucus secretion in man.
Acta hepatogastroenterol 25:292-294.
Douthwaite WA, Spence D (1986) Slit-lamp measurement of
the anterior chamber depth. Br J of Opthalmology 70:205-
208.
Elashoff JD, Grossmann MI (1980) Trends in hospital
admissions and death rates from peptic ulcer disease in
the United States from 1970 to 1978. Gastroenterology
78: 280-285.
Feldman M (1983) Gastric bicarbonate secretion in
humans. Effect of pentagastrin, bethanecol and 11,16,16-
trimethyl prostaglandin E2. J Clin Invest 72:295-303.
Ferreira SH (1981) A discussion on the mode of action of
non-steroid anti-inflammatory drugs: inhibition of
prostaglandin synthesis. In: the prostaglandin system. F
Berti, GP Velo (Eds) New York, Plenum Press pp 139-168.
Fitzpatrick FA, Aguirre R, Pike JE, Lincoln FH (1980)
The stability of 13,14-dihydro 15-keto PGE2.
Prostaglandins 19:917-931.
Fordyce MK, Christakis G, Kafatos A, Duncan R et al
(1983) Adipose tissue fatty acid composition of
adolescents in a US-Greece cross-cultural study of
151
coronary heart disease risk factors. J Chron Dis
36:481-486.
Friedman GD, Siegelaub AB, Selzer CC (1974) Cigarettes,
alcohol, coffee and peptic ulcer. N Engl J Med 290:
469-473.
Gillies MA, Skyring A (1969) Gastric and duodenal ulcer,
the association between aspirin ingestion, smoking and
family history of ulcer. Med J Austr 2:280-285.
Granstrom E, Kindahl H (1978) Radioimmunoassay of
prostaglandins and thromboxanes. In: Advances in
Prostaglandin and Thromboxane research. Edited by JC
Frohlich, Raven Press, New York Vol 5 119-209.
Granstrom E (1981) Biosynthesis of prostaglandins and
thromboxanes. In: The Prostaglandin System. F Berti, GP
Velo (Eds), New York, Plenum Press, pp 15-25.
Granstrom E, Diczfalusy U, Hamberg M, Hansson G et al
(1982) Thromboxane A2: biosynthesis and effects on
platelets . In: Prostaglandins and the cardiovascular
system. JA Oates (Ed) New York, Raven Press pp 15-58.
Grant HW, Palmer KR, Kelly RW, Wilson NH, Misiewicz JJ
(1988) Dietary linoleic acid, gastric acid and
prostaglandin secretion. Gastroenterology 94:955-959.
Guth PH, Aures D, Paulsen G (1979) Topical aspirin plus
HC1 gastric lesions in the rat. Cytoprotective effect
of prostaglandin, cimetidine and probantheline.
152
Gastroenterology 76: 88-93.
Hart Hansen 0, Pedersen T, Larsen JK (1975) A method to
study cell proliferative kinetics in human gastric
mucosa. Gut 16:23-27.
Hawkey CJ (1982) Evidence that prednisolone is
inhibitory to the cyclo-oxygenase activity of human
colonic mucosa. Prostaglandins 23:397-409.
Hawkey CJ, Simpson G, Somerville KW (1986) Reduction by
enprostil of aspirin-induced blood loss from human
gastric mucosa. Am J Med 81 (Suppl 2A):50-54.
Hawkey CJ, Walt RP (1986) Prostaglandins for peptic
ulcer: a promise unfulfilled. Lancet 2:1084-1086.
Hillier K, Smith CL, Jewell R, Arthur MJP , et al (1985)
Duodenal mucosa synthesis of prostaglandins in duodenal
ulcer disease. Gut 26:237-240.
Hinsdale JG, Engel JJ, Wilson DE (1974) Prostaglandin E
in peptic ulcer disease. Prostaglandins 6(6):495-500.
HMSO (1982) Ministry of Agriculture, Fisheries and Food.
Household Food Consumption and Expenditure 1980. Annual
Report of the National Food Survey Committee,
London:HMSO.
Hollander D, Tarnawski A, Ivey KJ, De Zeery A, et al
(1982) Arachidonic acid protection of rat gastric
mucosa against ethanol injury. J Lab Clin Med 100:296-
153
308.
Hollander D, Krause WJ, Strachura J et al (1985) Is
linoleic acid (dietary essential fatty acid - EFA)
cytoprotective for the gastric mucosa? Gastroenterology
88 (5 pt 2):1610.
Hollander D, Tarnawski A (1986) Dietary essential fatty
acids and the decline in peptic ulcer disease - a
hypothesis. Gut 27:239-242.
Horton EW, Main IHM, Thompson CJ, Wright PM ( 1968 )
Effect of orally administered prostaglandin E]_ on gastric
secretion and gastrointestinal motility in man. Gut
9 : 655-658.
Howard A, Pelc SR (1953) Synthesis of deoxyribonucleic
acid on normal and irradiated cells and its relation to
chromosomal breakage. Heredity, London 6 (Suppl):261-
Huang YS, Drummond R, Horrobin DF (1987) Protective
effect of gamma-linolenic acid on aspirin-induced gastric
haemorrhage in rats. Digestion 36:36-41.
Hunt JH, Franz DR (1981) Effect of prostaglandin E2 on
gastric mucosal bleeding caused by aspirin. Dig Dis Sci
26:301-305.
Illingworth CFW, Scott LDW, Jamieson RA (1944) Acute
perforated peptic ulcer. Br Med J 2:617-620 and 655-658.
Ippoliti AF, Isenberg J, Hagiel L (1981) Effect of oral
154
and intravenous 16, 16-dimethyl PGF2o^ on duodenal ulcer
and Zollinger Ellison syndrome patients.
Gastroenterology 80:55-60.
Isenberg JI, Hogan DL, Koss MA, Selling JA (1986) Human
duodenal mucosal bicarbonate secretion and stimulation by
hydrochloric acid and a synthetic prostaglandin E-j_
analogue. Gastroenterology 91:370-378.
Jamieson RA (1955) Acute perforated peptic ulcer. Br
Med J 2:222-227.
Jick H (1981) Effects of aspirin and acetaminophen in
gastrointestinal haemorrhage. Results from the Boston
Collaborative Drug Surveillance Programme. Arch Intern
Med 141:316-321.
Johansson GR (1985) Oral PGE2 inhibits gastric acid
secretion in man. Prostaglandins 29:143-152.
Johansson C, Kollberg B (1979) Stimulation by
intragastrically administered E2 prostaglandins of human
gastric mucus output. Eur J Clin Invest 9:229-232.
Jonasson TA, Brekkan A, Jonmundsson E, Bjarnason T,
Bonnevie 0 (1983) Epidemiological study of peptic ulcer
in Iceland. Scand J Gastroenterol 18(Suppl 86):32.
Kamentsky LA, Melamed MR, Derman H (1965)
Spectrophotometer - new instrument for ultrarapid cell
analysis. Science 150:630-631
155
Kelly RW, Abel MH ( 1983) The measurement of 13,14-
dihydro 15-keto prostaglandin E2 by combined gas
chromatography mass spectrometry. Mass spectrometry 10:
276-279 .
Kelly RW, Deans S, Cameron MJ, Seamark RF ( 1986 )
Measurement by radioimmunoassay of prostaglandins as
their methyloximes. Prost Leuk Med 24:1-14.
Kollberg B, Aly A, Rubio C, Johansson C (1981)
Acetazolamide interferes with the protective effect of
prostaglandin E2 in the rat gastric mucosa. Scand J
Gastroenterol 16:385-387.
Konturek SJ, Kwiecien N, Swierczek J, Oleksy J et al
(1976) Comparison of methylated prostaglandin E2
analogues given orally in the inhibition of gastric
responses to pentagastrin and peptone meal in man.
Gastroenterology 70:683-687.
Konturek SJ, Tasler J, Kwiecien N, Cieszkowski M (1978)
Mechanisms of the inhibitory action of prostaglandins on
meal-induced gastric secretion. Digestion 17:281-290.
Konturek SJ, Swierczek JS, Kwiecen N, Obtulowicz W et al
(1979) Effect of orally administered 15(R)-15-methyl
PGE2 and/or an anticholinergic drug on meal-induced
gastric acid secretion and serum gastrin level in
patients with duodenal ulcers. Scand J Gastroenterology
14:813-819.
156
Konturek SJ, Bowman J, Lancaster C, Hancher AJ et al
(1979) Cytoprotection of the canine gastric mucosa by
prostacyclin: possible mediation by increased mucosal
blood flow. Gastroenterology 76:1173.
Konturek SJ, Obtulowicz W, Sito E, Oleksy J et al (1981)
Distribution of prostaglandins in gastric and duodenal
mucosal of healthy subjects and duodenal ulcer patients:
effects of aspirin and paracetamol. Gut 22:283-289.
Konturek SJ, Piastucki I, Brzozowski T, Radecki T et al
(1981) Role of prostaglandins in the formation of
aspirin-induced gastric ulcers. Gastroenterology 80:4-9.
Konturek SJ, Brzozanski T, Piastucki I, Radecki T et al
(1982) Role of locally generated prostaglandins in
adaptive gastric cytoprotection. Dig Dis Sci 27(11):967-
971.
Konturek SJ, Bilski J, Kwiecien N, Obtulowicz W et al
(1987) De-nol stimulates gastric and duodenal alkaline
secretion through prostaglandin dependent mechanism. Gut
28:1557-1563.
Kurata JH, Haile BM (1984) Epidemiology of peptic ulcer
disease. In: Isenberg JI, Johansson C (Eds). Clinics in
gastroenterology: peptic ulcer disease. London: WB
Saunders 289-308.
Kurzok R (1930) Biochemical studies of human semen: II
the action of semen on the human uterus. Proc Soc Exp
1 57
Biol Med 28:268-272.
Lacy ER, Ito S (1984) Ethanol-induced insult to the
superficial rat gastric epithelium: a study of damage and
rapid repair. In: Mechanisms of mucosal protection in
the upper gastro-intestinal tract. A Allen, G Flenstrom,
A Garner, W Silen, L Turnberg (Eds) New York, Raven Press
pp 49-54.
Langman MJS (1979) Peptic ulcers . In: The epidemiology
of chronic digestive disease. MJS Langman (Ed) London,
E Arnold 9-39.
Leblond CP, Stevens CE, Bogoroch R (1948) Histological
localisation of newly formed deoxyribonucleic acid.
Science 108:531-533.
Levine RA, Kohen R, Shwartzek EH, Ramsay CE (1982)
Prostaglandins E2 - histamine interactions on cAMP, cGMP
and acid production in isolated fundic glands. Am J
Physiol 242:G21-G29.
Litton A, Murdoch WR (1963) Peptic ulcer in South-West
Scotland. Gut 4:360-366.
Lupulescu A (1975) Effect of prostaglandins on protein,
RNA, DNA and collagen synthesis in experimental wounds.
Prostaglandins 10(4):573-9.
Mahachai V, Walker K, Sevelius H, Thomson AB (1985)
Antisecretory and serum gastrin lowering effect of
158
Enprostil in patients with duodenal ulcer disease.
Gastroenterology 89:555-61.
Mahoney JM, Waterbury LD (1981) The effect of orally
administered prostaglandins on gastric mucus secretion in
the rat. Prostaglandins and Medicine 7:101-107.
Mendeloff AI (1974) What has been happening to duodenal
ulcer? Gastroenterology 67:1020-1022.
Miller T (1983) Protective effects of prostaglandins
against gastric mucosal damage: current knowledge and
proposed mechanisms. Am J Physiol 245:G601-G623.
Miller TA, Gum ET, Guinn EJ, Henagan JM (1982)
Prostaglandin prevents alteration in DNA, RNA and protein
in damaged gastric mucosa. Dig Dis Sci 27:776-81.
Moncada S, Salmon JA, Vane JR, Whittle BJR ( 1977 )
Formation of prostacyclin and its product 6-oxo PGF-^q^ by
the gastric mucosa of several species. J Physiol
(London) 275:4-5.
Mueller GC (1971) Biochemical perspectives of the GI and
S intervals in the replication cycle of animal cells: a
study in the control of cell growth. In: Cell Cycle and
Cancer 269-307. R Baserga (Ed), Marcel Dekker Inc, New
York, USA.
Mullaney PF, Van Dilla MA, Coulter JR et al (1969) Cell
sizing: a light scattering photometer for rapid volume
determination. Rev Sci Instrum 40:1029-32.
159
McGiff JC, Crawshaw K, Terragno NA, Malik KU et al (1972)
Differential effect of noradrenaline and renal nerve
stimulation on vascular resistance in the dog kidney and
the release of prostaglandin E-like substance. Clin Sci
42:223-233.
MacKay C (1966) Perforated peptic ulcer in the West of
Scotland. Br Med J 1:701-705.
Nylander B, Andersson S (1974) Gastric secretory
inhibition induced by three methyl analogues of
prostaglandin E2 administered intragastrically to man.
Scand J Gastroenterol 9:751-758.
Oates PJ, Hakkinen JP (1988) Studies on the mechanism of
ethanol-induced gastric damage in rats. Gastroenterology
94:10-21.
Peskar BM, Seyberth HW, Peskar BA (1980) Synthesis and
metabolism of endogenous prostaglandins by human gastric
mucosa. In: Advances in prostaglandin and thromboxane
research Vol 8, edited by B Samuelsson, PW Ramwell and
R Paoletti, Raven Press, New York. 1511-1514
Piper DW, Mcintosh JH, Ariotti DE, Fenton BH et al (1981)
Analgesic ingestion and chronic peptic ulcer.
Gastroenterology 80:427-432.
Piper PJ, Vane JR (1971) The release of prostaglandins
from lung and other tissues. Ann NY Acad Sci 180:
1 60
363-385.
Pritchard P, Brown G, Bhaskar N, Hawkey CJ (1988) The
effect of dietary fatty acids on the gastric production
of prostaglandins and aspirin-induced injury. Aliment
Pharmac Therap 2:1-6.
Pugh S, Williams SE, Levin MR, Ishague M et al (1989)
Duodenal and antral mucosal prostaglandin E2 synthesis in
a study of normals and all stages of duodenal ulcer
disease treated by H2 receptor antagonists. Gut 30(2):
161-165
Pulvertaft CN (1959) Peptic ulcer in town and country.
Br J Prev Soc Med 13:131-139.
Pulvertaft CN (1968) Comments on the incidence and
natural history of gastric and duodenal ulcer. Postgrad
Med J 44:597-602.
Rachmilewitz D, Ligumsky M, Fich A, Golden E, et al
(1986) The role of endogenous gastric prostanoids in
the pathogenesis and therapy of duodenal ulcer.
Gastroenterology 90:963-969.
Rees WDW, Gibbons LC, Warhurst G, Turnberg LA (1984)
Studies of bicarbonate secretion by the normal human
stomach in vivo. Effect of aspirin, sodium taurocholate
and PGE2. In : Allen A, Flenstrom G, Garner A, Silen W,
Turnberg L (eds). Mechanisms of gastric mucosal
protection in the upper gastro-intestinal tract. New
161
York, Raven, 1984:119-124.
Reinhart WH, Muller 0, Halter F (1983) Influence of
long-term 16, 16-dimethyl prostaglandin E2 treatment on
the rat gastrointestinal mucosa. Gastroenterology
85: 1003-10.
Rhys Davies E (1984) Non-invasive radiology. Radio¬
nuclide investigations. Clin Gastroenterol 13 (l):205-233
Robert A (1979) Cytoprotection by prostaglandins.
Gastroenterology 77:761-767.
Robert A, Nezamis JE, Lancaster L, Hancher AJ (1979)
Cytoprotection by prostaglandins in rats. Prevention of
gastric necrosis produced by alcohol, HCl, NaOH,
hypertonic NaCl and thermal injury. Gastroenterology
77 : 433-43.
Robert A (1981) Prostaglandins and the gastro-intestinal
tract. In: physiology of the gastro-intestinal tract. LR
Johnson (Ed) New York, Raven Press pp 1407-1434.
Robert A, Nezamis JE, Lancaster C, Davis JP et al (1983)
Mild irritants prevent gastric necrosis through "adaptive
cytoprotection" mediated by prostaglandins. American
Journal of Physiology 245:G113-121.
Robert A (1984) Distinction between anti-ulcer effect
and cytoprotection. Scand J Gastroenterol 19 (Suppl
101) : 69-95 .
1 62
Roshanai F, Sanders TAB (1984) Assessment of fatty acid
intakes in vegans and oranivores. Hum Nutr Appl Nutr
38(5):345-354.
Samuelsson B, Granstrom E, Green K, Hamberg M et al
(1975) Prostaglandins. Ann Rev Biochem 45:669-695.
Schepp W, Steffen B, Ruoff HJ, Schusdiaziarra V et al
(1988) Modulation of rat gastric mucosal prostaglandin
E2 release by dietary linoleic acid: effect on gastric
secretion and stress induced mucosal damage.
Gastroenterology 95 :18-25.
Sellers LA, Carroll NJH, Allen A ( 1986) Misoprostol-
induced increases in adherent gastric mucus thickness and
luminal mucus output. Dig Dis Sci (Suppl) 31(2):91S-95S.
Shapiro BE, Felberg NT, Donoso LA, Augsberger JJ et al
(1986) Flow cytometry of uveal melanomas. Cancer Biochem
Biophys 8(3): 235-238.
Sharon P, Cohen F, Zifroni A, Karmeli F et al (1983)
Prostanoid synthesis by cultured gastric and duodenal
mucosa: possible role in the pathogenesis of duodenal
ulcer. Scand J Gastroenterol 18:1045-1049.
Sih CJ, Takeguchi C, Foss P ( 1970) Mechanisms of
prostaglandin biosynthesis. 3. Catecholamines and
serotonin as co-enzymes. J Am Chem Soc 92:6670.
Soil AH (1978) Prostaglandin inhibition of histamine-
stimulated aminopyrine uptake and cyclic AMP generation
163
by isolated canine parietal cells. Gastroenterology
74(5):1146.
Soil AH (1980) Specific inhibition of prostaglandins E2
and I2 of histamine stimulated (^C) aminopyrine
accumulation and cAMP generation by isolated canine
parietal cells. J Clin Invest 65:1222-1229.
Sonnenberg A, Muller H, Fabio P (1985) Birth-cohort
analysis of peptic ulcer mortality in Europe. J Chronic
Dis 38:309-17.
Sontag S, Graham D, Belsito A, Weiss J et al (1984)
Cimetidine, cigarette smoking, and recurrence of duodenal
ulcer. New Engl J Med 311:689-693.
Spenney JG , Brown M (1977) Effect of acetyl-salicylic
acid on gastric mucosa. Gastroenterology 73:995-999.
Stiel D, Ellard KT, Hills LJ, Brooks PM (1986)
Protective effect of enprostil against aspirin-induced
injury in man. Comparison with cimetidine and
sucralfate. Am J Med 81(Suppl 2A):54-58.
Svanes K, Leiknes KA, Varhaug JE, Soreide 0 (1979)
Aspirin damage to ischaemic gastric mucosa in shocked
cats. Scand J Gastroenterol 14:633-639.
Svanes K, Ito S, Takeuchi K, Silen W (1982) Restitution
of the surface epithelium of the in vitro frog gastric
mucosa after damage with hyperosmolar sodium chloride:
1 64
morphological and physiological characteristics.
Gastroenterology 82:1409-1426.
Tarnawski A, Hollander D, Stachura S,Krause WJ (1983)
Arachidonic acid protection of gastric mucosa against
alcohol injury: segmental analysis of morphological and
functional changes. J Lab Clin Med 102:340-351.
Tarnawski A, Hollander D, Stachura J (1985) Is linoleic
acid (dietary essential fatty acid) cytoprotective for
the gastric mucosa? Gastroenterology 88(S):1610
Tarnawski AJ, Hollander D, Stachura J, Krause WJ et al
(1985) Prostaglandin protection of the gastric mucosa
against alcohol injury - a dynamic time-related process.
Gastroenterology 88:334-52.
Tepperman BL, Miller TA, Johnson LR (1978) Effect of
16,16-dimethyl prostaglandin E2 on ethanol-induced damage
to canine oxyntic mucosa. Gastroenterology 75:1061-1065.
Tobey RA, Peterson DF, Anderson EC (1971) Biochemistry
of G2 and mitosis. In: The Cell Cycle and Cancer:309-
353. R Baserga (Ed) Marcel Dekker Inc, New York, USA.
Traganos F, Danzynkiewicz Z, Sharpless T et al (1977)
Simultaneous staining of ribonucleic acid and
deoxyribonucleic acids in unfixed cells using acridine
orange in a flow cytofluorometric system. J Histochem
Cytochem 25(l):46-56.
165
Tytgat GNJ, Huibregtse K (1981) Effect of 15(R)-15
methyl prostaglandin E2 on basal and meal-stimulated
serum gastrin in duodenal ulcer patients. Prostaglandins
21(Suppl):53-56.
Tytgat GN, Henzen-Logmans S, van Minnen AJ (1982) Human
gastric mucosal changes after oral 15(R)-15 methyl
prostaglandin E2 administration. Gastroenterology
82:1200.
Van Essen HA, Van Blankenstein M, Wilson JHP, Bakker WH
(1985) Orthotolidine test not to be used for detection
of blood in gastric juice. Clin Chem Acta 150(3):
255-259.
Van Staveren WA, Deurenberg P, Katan MB, Burema J et al
(1986). Validity of the fatty acid composition of
subcutaneous fat tissue microbiopsies as an estimate of
the long-term average fatty acid composition of the diet
of separate individuals. Am J Epidemiol 123:455-463.
Van Trappen G, Janssens J, Popiela T, Kulig J et al
(1982) Effect of 15(R) 15-methyl prostaglandin E2
(arbaprostil) on the healing of duodenal ulcers.
Gastroenterology 83:357-363.
Vane JT (1971) Inhibition of prostaglandin synthetase as
a mechanism of action for aspirin-like drugs. Nature
231:232-235.
Wang DL, Reitz RC (1983) Ethanol ingestion and
1 66
polyunsaturated fatty acids: Effects on the acyl-CoA
desaturases. Alcoholism (NY);7 (2): 220-226.
Waterbury LD, Mahoney JM, Peak TM, Cohn RG et al (1986)
Stimulatory effect of Enprostil, an anti-ulcer
prostaglandin on gastric mucus secretion. Am J Med
81(Suppl 2A):30S-33S.
Welsh SO, Marston RM (1982) Review of trends in food use
in the United States, 1909 to 1980. J Am Dietetic Assoc
81:120-8.
Williams SE, Turnberg LA (1980) Retardation of acid
diffusion by pig gastric mucus: a potential role in
mucosal protection. Gastroenterology 79:299-304.
Williams TJ (1983) Interactions between prostaglandins,
leukotrienes and other mediators of inflammation. Br Med
Bull 39:239-242.
Wood DA, Riemersma RA, Butler S, Thomson M, Maclntyre C,
Elton RA, Oliver MF (1987) Linoleic and
eicosanpentaenoic acids in adipose tissue and platelets
and risk of coronary heart disease. Lancet 1:177-183.
Zlotoff RA, Lake AM, Hamilton SR, Hendrix TR et al
(1982) N-acetyl cysteine attenuates the cytoprotective




I would like to express my gratitude to the following
people for their assistance during this research :
Dr Kelvin Palmer, Consultant Physician, Gastro-Intestinal
Unit, Western General Hospital for his supervision during
my research, his encouragement, friendship and support,
and his criticism and advice when needed.
Dr Rodney Kelly, MRC Reproductive Biology Unit,
Edinburgh for the use of his department and resources in
carrying out the radioimmunoassays.
Dr Norrie Wilson, Department of Pharmacology, Edinburgh
University for his assistance in validating the linoleic
acid by GC-MS.
Department of Haematology, Western General Hospital, for
radio-labelling red cells with Cr5-1".
Mr C Farrington, Department of Medical Physics, Western
General Hospital, for counting radioactive labelled
blood and faeces.
Mr J Bode, GI Laboratories, Western General Hospital, for
his assistance in preparing microscopy slides.
Mr A Smith, University Department of Pathology for
assistance in developing autoradiography slides.
Mr Graeme Wilson , GI Laboratories, for his expertise in
1 68
flow cytometry.
Dr R Riemersma, Cardiovascular Research Laboratory, for
measuring linoleic acid levels in fat biopsies.
Dr G Brydon, GI Laboratories, Western General Hospital,
for his advice on mucus assays.
Glasgow Royal Infirmary, Biochemistry Department for
estimating serum gastrin levels.
Sister S Crichton of the Gastro-Intestinal Investigation
Suite for assistance in the collection of samples.
Dr A Lessells, Consultant Pathologist, Western General
Hospital, for assessing the pathology of the slides.
Miss C Tait and Miss A Stewart for assistance with
editing and word processing.
169
GASTROENTEROLOGY 1988:94:958-9
Dietary Linoleic Acid, Gastric Acid, and
Prostaglandin Secretion
H. W. GRANT, K. R. PALMER, R. W. KELLY, N. H. WILSON,
and J. J. MISIEWICZ
Gastrointestinal Unit. Western General Hospital, Edinburgh: MRC Unit of Reproductive Biology.
Edinburgh; Department of Pharmacology, University of Edinburgh. Edinburgh: and Department
of Gastroenterology and Nutrition. Central Middlesex Hospital. London. United Kingdom
Basal and pentagastrin-stirnulated gastric acid se¬
cretion, fasting serum gastrin concentrations, and
the gastric output of prostaglandin E and its major
metabolite 13,14-dihydro 15-keto prostaglandin E2
were measured in 9 normal subjects before and after
14—20 days of dietary supplementation with linoleic
acid. Mean maximal gastric acid output fell from
36.0 ± 3.3 (SEM) to 30.1 ± 2.9 mmol/h (p < 0.05),
although mean basal acid output was not signifi¬
cantly affected (8.3 ± 2.1 and 7.2 ± 1.7 mmol/h,
respectively). Mean fasting serum gastrin concen¬
trations increased from 19.2 ± 3.1 to 30.9 ± 3.8 ng/L
(p < 0.01) after linoleic acid, probably because of
acid suppression. The mean output of prostaglandin
E increased from 498 ± 110 to 1254 ± 465 ng/h (p <
0.05); that of its metabolite increased from 165 ± 18
to 1168 ± 645 ng/h (p < 0.01). These findings show
that in normal subjects essential fatty acid weakly
inhibits gastric acid secretion, but considerably in¬
creases gastric prostaglandin output.
In the Western hemisphere the incidence and vir¬ulence of peptic ulcer have decreased during the
past four decades (1), whereas the average per capita
consumption of polyunsaturated fatty acids has in¬
creased by >300% (2). Hollander and Tarnawski (3)
have suggested that these two observations are re¬
lated. Feeding polyunsaturated essential fatty acids
(linoleic and arachidonic acids) to experimental an¬
imals leads to massive increases in prostaglandin
concentrations in gastric juice (4,5) and these pre¬
vent experimental mucosal injury (5). Prostaglan¬
dins and prostaglandin analogues also profoundly
affect human gastric function. In pharmacologic
doses they suppress acid secretion (6), stimulate
secretion of mucus and bicarbonate (7,8), and protect
the gastric mucosa against the harmful effects of
salicylates (9). bile acids (10), and etHanoi (11). Their
effects on gastrin release arc controversial; they have
been variously reported to decrease (12) or have no
effect on (13) serum gastrin concentrations. In¬
creased intake of polyunsaturated fatty acids could
therefore lead to lowered acid secretion and in¬
creased gastric mucosal protection. In this study the
effects of oral linoleic acid on the gastric mucosal
metabolism of prostaglandins, gastric acid secretion,
and plasma concentrations of gastrin were measured
in normal subjects. Linoleic rather than arachidonic
acid was chosen because of its greater chemical
stability and because linoleic acid is the major di¬
etary polyunsaturated fatty acid. Free linoleic acid
rather than the naturally occurring triglyceride was
used as this simplifies its incorporation into the
biosynthetic pathway of prostaglandins.
Materials and Methods
Materials
Linoleic acid was prepared as a micellar solution in
nonionic detergent (Pluronic F68). Experiments in animals
(4) have shown Pluronic F68 to be completely nontoxic
and to have no effect on prostaglandin metabolism. Gela¬
tin-coated capsules each containing 500 mg of linoleic
acid and 320 mg of Pluronic F68 (Au-C003) were prepared
by International Pharmaceuticals Inc., Costa Mesa. Calif.
Capsules rapidly dispersed in both water and gastric acid
at room and body temperature.
Subjects
Nine healthy, nonsmoking, white male volunteers
(age range 20—41 yr) were studied. None had dyspepsia or
gastroduodenal disease, abused alcohol, or consumed
drugs of any description. All were taking a normal western
diet before the study and were instructed not to change it
during the study period.
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Design of Ihe Study
After an overnight fast venous blood was taken
from each subject for measurement of hemoglobin concen¬
tration. white cell count, platelet count, erythrocyte sedi¬
mentation rate, and serum urea, creatinine, electrolytes,
bilirubin, aspartate transaminase, glucose, thyroxine, and
gastrin concentrations. Upper gastrointestinal endoscopy
was performed using an Olympus XQ10 forward-viewing
endoscope (Olympus Corp. of America, New Hyde Park,
N.Y.). Lignocaine spray was used to anesthetize the phar¬
ynx but intravenous sedation was not given. Two biopsy
specimens, each measuring —2-4 x 2 mm, were taken
from the gastric antrum and the first part of the duodenum
and processed for light and electron microscopy. Speci¬
mens for light microscopy were embedded in paraffin and
stained using hematoxylin and eosin. Sections for electron
microscopy were embedded in plastic, then impregnated
with uranyl acetate and lead citrate. Three grids were
examined in a JEOL CX2 transmission electron microscope
QEOL USA. Peabody, Mass.) using an operating voltage of
60 kV. After endoscopy a nasogastric tube was swallowed
and the gastric contents were aspirated under continuous
suction at 15-min intervals for 75 min. Pentagastrin (6
Mg/kg) was then injected subcutaneously and four further
15-min aspirates were collected. The subjects were subse¬
quently randomized to receive three capsules (1.5 g of
linoleic acid and 960 mg of Pluronic F68) or six capsules (3
g of linoleic acid and 1920 mg of Pluronic F68) taken in
equal divided doses at eight hourly intervals. They were
interviewed after 2—4 days to assess compliance and ad¬
verse effects and then studied again 14—19 days after
starting linoleic acid. Exactly 1 h after the last dose of
linoleic acid, blood was taken for hematology and bio¬
chemistry studies and serum gastrin concentration mea¬
surement. Upper gastrointestinal endoscopy with biopsy
and a pentagastrin-stimulated acid study exactly as de¬
scribed above were again performed.
Assays
Serum gastrin concentrations were measured by
radioimmunoassay (Department of Biochemistry, Glasgow
Royal Infirmary). Rabbit antigastrin serum was used. The
sensitivity was 15.24 ng/L (normal range 30-120 ng/L).
Gastric acid concentrations were determined in 5-ml
aliquots of gastric juice by titration to pH 7 with 0.1 M
NaOH using a PHM 82 standard pH meter (Radiometer,
Copenhagen, Denmark). Gastric ac'd outputs were calcu¬
lated from the product of concentration and volume. Basal
acid output was derived from the juice collected before
pentagastrin and maximal acid output from the sum of the
four aliquots taken after pentagastrin. Prostaglandin con¬
centrations were measured in samples of gastric juice that
had been stored at -20°C. After aspiration each sample
was immediately adjusted to pH 7 using 0.1 M NaOH to
minimize conversion of prostaglandin E (PGE) to
prostaglandin A (PGA) and then frozen. Prostaglandin E
and its major metabolite 13,14-dihydro 15-keto PGE2 were
measured exactly as described by Kelly et al. (14). Briefly,
antisera to conjugated PGE2 and 13,14-dihydro 15-keto
PGE2 were raised in New Zealand white rabbits. Radioim¬
munoassay of methyl oximated samples was done using
polyethylene glycol precipitation of bound label to which
bovine y-globulin had been added. Specificity had previ¬
ously been determined by gas chromatography and mass
spectrometry. There was 53% cross-reactivity between
PGE, and PGE2 and 31% between PGE3 and PGE2, but no
reactivity with PGA or 6-oxo PGF,^ Interassay and intraas-
say precision of 13,14-dihydro 15-keto PGE2 were 9.4 and
4.9-7.6. respectively (relative standard deviations). Those
for PGE were 14.8 and 13.5-26.4. respectively. Prostaglan¬
din outputs were calculated from the products of concen¬
tration and volume.
Ethical permission was obtained from the Lothian Ethics
of Medical Research Sub-Committee for Medicine and
Clinical Oncology.
Statistical Methods
The Wilcoxon rank sum test for paired data and
Student's paired t-test were used where appropriate.
Results
Endoscopic appearances of the stomach and
duodenum, light and electron microscopic findings,
and routine hematology and biochemistry studies
were normal and unchanged throughout the study
Table 1. Mean (± SEM) Gastric Acid Secretion, Fasting Serum Gastrin Concentrations, and Total Gastric
Prostaglandin Outputs Before and After Dietary Linoleic Acid
1.5 g LA (n = 5) 3.0 g LA (n = 4) All subjects (n = 9)
Variable Before After Before After Before After
Basal acid output 9.94 - 3.0 8.52 - 2.4 6.18 * 2.9 5.54 - 2.4 8.3 - 2.1 7.2 £ 1.7
(mmo//h)
Maximal acid output 36.67 - 2.88 31.09 - 3.58 35.24 - 7.09 28.88 - 5.4 36.0 - 3.3 30.9 £ 2.9
ImmoJ/h)
Fasting serum gastrin 22.4 £ 4.8 33.4 - 4.6 15.25 £ 3.7 27.75 - 7.12 19.2 £ 3.2 30.9 £ 3.8"
concentration
|ng/L)
PCE output Ing/h) 452 £ 77 744 ± 127 554 s 246 1891 - 1014 498 £ 110 1254 £ 465"
PGEM output (ng/h) 154 - 20 274 - 84 180 - 34 2287 £ 1318 165 £ 18 1168 £ 645°
LA. linoleic acid: PGE. prostaglandin E; PGEM. 13.14-dihydro 15-keto prostaglandin E2. 'p< 0.01. Student's t-test. b p < 0.05. Student s
t-lest.
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period in all subjects. Five subjects were randomized
to 1.5 g of linoleic acid: 4 other subjects received 3 g
daily. Four subjects developed mild diarrhea during
the study, which ceased on discontinuing linoleic
acid. One subject experienced an exacerbation of
pain from a chronic musculoskeletal injury. All
subjects were nevertheless fully compliant. The ef¬
fects of oral linoleic acid on gastric acid secretion,
fasting serum gastrin concentrations, and gastric
prostaglandin output are summarized in Table 1.
Although basal acid secretion tended to decrease
after treatment with linoleic acid, this trend just
failed to achieve statistical significance (p < 0.06).
There was however a small but significant fall in
mean pentagastrin-stimuiated gastric acid output
after linoleic acid. Inhibition of acid secretion
tended to be greater in those subjects who received 3
g rather than 1.5 g per day, although the small
numbers preclude a statistical analysis. The results
of mean gastric acid secretion before and after
linoleic acid ingestion are depicted in Figure 1.
Fasting serum gastrin concentrations increased after
linoleic acid ingestion in all but 1 subject (Figure 2).
There was no obvious relationship between serum
gastrin concentrations and the daily dose of linoleic
acid, nor with basal or pentagastrin-stimuiated acid
secretion. Gastric PGE output increased markedly
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Figure 2. Fasting serum gastrin concentrations before and after
linoleic acid (LA). Subjects received 1.5 or 3.0 g of
linoleic acid daily.
major metabolite 13,14-dihydro 15-keto PGE2 (Fig¬
ure 4). The highest values were present in the first
gastric aspirates, but outputs were also significantly
higher throughout the period of gastric aspiration.
Concentration rather than volume changes were re¬
sponsible for this increase.
Discussion
This study has shown that in normal individ¬
uals dietary supplementation with relatively modest
amounts of linoleic acid results in a small, but
significant, fall in mean pentagastrin-stimuiated gas¬
tric acid secretion and increased mean fasting serum
gastrin concentrations. We suggest that these effects
are the result of increased gastric prostaglandin
synthesis.
The modest fall in gastric acid secretion suggests
that linoleic acid will not be a potent duodenal ulcer
healing agent. It is nevertheless interesting that olive
and linseed oils, both rich in linoleic acid, were once
traditional remedies for dyspepsia. Acid secretion
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tends to be high in patients with duodenal ulcer (15),
and the effect of linoleic acid on acid secretion
observed in this study could therefore account for the
observed inverse relationship between the incidence
of peptic ulcer and per capita consumption of poly¬
unsaturated fat. There is evidence that in addition to
the effect on gastric acid secretion, prostaglandins
are involved in the prevention of gastroduodenal
ulcers and healing of ulcers by factors enhancing
mucosal defense rather than ones that are indepen¬
dent of acid suppression (16). Stimulation by
linoleic acid of endogenous gastroduodenal prosta¬
glandin formation may therefore also affect the nat¬
ural history of peptic ulcer by enhancing such "mu¬
cosal protective" factors.
The effects of prostaglandins and prostaglandin
analogues on serum gastrin concentration are con¬
troversial. Tytgat and Huibiegtse (13) reported that
mean serum gastrin concentrations in duodenal ul¬
cer patients were unchanged after treatment with 15
(R)-15-methyl PGE2, whereas Mahachai et al. (12)
observed a significant fall after 1 wk of the PGE2
analogue enprostil. It has been suggested that pros¬
taglandins may suppress gastric acid secretion by
decreasing gastrin release (12). It is likely that serum
gastrin concentrations increased in our experiment
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figure 3. Mean (i SEM) gastric prostaglandin E output before
and after linoleic acid (LA).
Figure 4. Mean gastric 13.14-dihydro 15-keto PGE, (PGEM) out¬
put before and after linoleic acid (LA).
effects occur with other agents that suppress gastric
acid secretion (17,18).
The output of PGE reported in this study before
dietary linoleic acid supplementation is similar to
that found in a group of normal subjects by Cheung
et al. (19). These workers collected samples by
nasogastric tube without prior endoscopy or gastric
mucosal biopsy. It is therefore unlikely that the
trauma of endoscopy and mucosal biopsy signifi¬
cantly affected prostaglandin output in our study.
Each subject acted as his own control and changes in
PGE, 13,14-dihydro 15-keto PGE2, and acid output
and the increase in serum gastrin concentrations
after linoleic acid cannot therefore be explained by
this theoretical artifact. The increase in gastric
prostaglandin output observed in this study is sev¬
eral orders less than that observed in rodents (4.5). It
is possible that the peak prostaglandin concentra¬
tions occur almost immediately after linoleic acid.
Our observation that early prostaglandin concentra¬
tions were highest supports this suggestion, al¬
though an altered response to the trauma of endos¬
copy, biopsy, and nasogastric intubation is an
alternative possibility. We chose to start aspirating
the stomach contents 1 h after the subjects swal¬
lowed the last capsules because earlier sampling
would have removdtl significant amounts of linoieic
acid. We cannot tell whether the effects of linoleic
p«0.01
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acid on gastric secretion and serum gastrin concen¬
trations are due to chronic administration or would
follow a single dose of linoieic acid. We speculate
that dietary linoieic acid passively diffuses down its
concentration gradient into gastric mucosal cells and
is then incorporated into the prostaglandin cascade,
leading to an outpouring of PGE into gastric juice.
The early peak in PGE output in experimental ani¬
mals (4) and humans supports this and suggests that
the effects of linoieic acid are acute rather than due
to chronic administration. Whether the approxi¬
mately threefold increase in prostaglandin output
could be physiologically, pharmacologically, or ther¬
apeutically important is unknown. We have demon¬
strated small, but significant, changes in acid and
gastrin concentrations and others have suggested
that prostaglandin analogues heal ulcers by so-called
cvtoprotective mechanisms in addition to their acid-
suppressing effect (16). Although our observations
are compatible with the hypothesis of Hollander and
Tarawski (3). this study is obviously some way from
proving an association between peptic ulcer and
polyunsaturated fat ingestion. A study of peptic
ulcer patients is clearly necessary, particularly as
gastroduoaenal prostaglandin metabolism may be
abnormal in this disease (19,20).
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